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SUMMARY 
 
Medullary thymic epithelial cells (mTEC) play an essential role in the establishment of 
central tolerance as they express rare, otherwise tissue-restricted antigens. The 
overall contribution of direct antigen presentation by mTEC as opposed to mere 
provision of antigens, however, remains to be established.  
Here, we generated a transgenic mouse (C2TAkd) expressing a “designer miRNA” 
against C2TA, the master regulator of MHCII, specifically in mTEC. Tissue-specific 
and efficient knock-down of C2TA was observed in mTEC, but not in other thymic 
stromal cell types. In C2TAkd mice the polyclonal CD4+ single positive compartment 
was enlarged and CD4+ thymocytes were self-reactive in vitro, presumably due to 
impaired negative selection. In several TCR transgenic models of tolerance to 
mTEC-derived self-antigens diminished negative selection was observed when 
interfering with antigen presentation by mTEC, irrespective of whether potentially 
cross-presenting dendritic cells (DC) were present or not. In addition we found that 
reduced antigen presentation by mTEC shifted the mode of tolerance from negative 
selection towards regulatory T cell (Treg) development which is in support of an avidity 
model of Treg induction. 
Taken together we propose a dual function for mTEC in CD4+ T cell tolerance as 
antigen reservoir and as antigen presenting cells.  
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ZUSAMMENFASSUNG 
 
Medulläre thymische Epithelzellen (mTEC) spielen eine wichtige Rolle für die 
Entstehung zentraler Toleranz, da sie gewebsspezifische Antigene exprimieren. Die 
Relevanz direkter Antigenpräsentation, im Gegensatz zur ausschließlichen 
Produktion von Antigenen durch mTEC, ist undurchsichtig. 
Diese Arbeit beschreibt die Generierung einer Transgenen Maus (C2TAkd), die eine 
„Designer miRNA“ gegen C2TA, den Hauptregulator von MHCII, spezifisch in mTEC 
exprimiert. Der gewebsspezifische und effiziente Knockdown von C2TA konnte in 
mTEC, nicht jedoch in anderen thymischen Stromazellen detektiert werden. In 
C2TAkd Tieren fanden wir eine vergrößerte CD4+ einfach positive T-Zell Population, 
die CD4+ Zellen mit autoreaktivem Potential enthielt, was wahrscheinlich auf einen 
Defekt in der negativen Selektion zurückzuführen ist. Des weiteren führte die 
Inhibierung von MHCII in mTEC in mehreren Mausmodellen, in denen ein  von 
mTEC produziertes Antigen zusammen mit einem   T-Zell Rezeptor spezifisch für das 
Antigen exprimiert wurde, zu einer Verminderung der negativen Selektion. Diese 
Beobachtung konnte in An- und Abwesenheit von Dendritischen Zellen (DC) 
gemacht werden. Darüber hinaus konnten wir in den T-Zell Rezeptor transgenen 
Modellen mit verminderter Antigenpräsentation durch mTEC eine Verschiebung von 
negativer Selektion Richtung Induktion von regulatorischen T-Zellen (Treg) feststellen. 
Dies ist ein starker Hinweis darauf, dass die Entwicklung von Treg auf einem 
Aviditätsmodell beruht. 
Wir vertreten die These, dass mTEC eine zweifache Funktion in der 
Toleranzinduktion von CD4+ T-Zellen innehaben, als Antigenreservoir und als 
Antigen präsentierende Zellen. 
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1. INTRODUCTION 
 
The immune system is a remarkably old “institution” as even the most primitive 
multicellular organisms have some kind of defense mechanism against potentially 
dangerous pathogens. Innate immunity is a hallmark of all metazoan species and 
depends, amongst others, on the recognition of highly conserved pathogen 
associated molecular patterns (PAMPS) by germ line–encoded pattern recognition 
receptors. Microorganisms on the other hand steadily develop new strategies to 
evade these host defense tactics, thereby constantly putting immense selective 
pressure on the host. Thus, there is a permanent need to respond to new and 
improved invaders, which most likely led to the evolution of a new, highly 
sophisticated defense mechanism, the so called adaptive immune system (1, 2).  
The adaptive immune system first can be found in jawed vertebrates, and in a 
rudimentary form also in jawless vertebrates. Unlike the innate immune system it is 
characterized by the remarkable ability to specifically respond to virtually any given 
pathogen.  The enormous diversity and flexibility of the adaptive immune system is 
ensured by different lymphocyte species and their ability to perform somatic 
diversification of antigen receptor genes, thereby generating a vast repertoire of cells, 
each of which expressing a different antigen receptor. Antigen recognition by specific 
lymphocyte clones initiates a sequence of inter-depending processes including 
proliferation, differentiation and production of specific antibodies.  
Representing the major lymphocyte populations, T cells are primarily responsible for 
cell-mediated immunity while B cells are mediating antibody responses or humoral 
immunity, whereby their cross-talk is indispensible for an effective immune response. 
Another hallmark of the adaptive immune system is its ability to memorize previously 
encountered pathogens, enabling the host to erase future infections more quickly and 
efficiently.  
The generation of a nearly infinite antigen receptor repertoire is made possible by the 
perpetual development of new lymphocytes and the somatic rearrangement of their 
V-D-J immunoglobulin gene segments. As this process is entirely random it is an 
obvious consequence that also potentially harmful receptors recognizing self 
constituents are generated. Mechanisms of tolerance induction have therefore 
arisen, eliminating auto-reactive lymphocytes and leading to the ability to distinguish 
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harmful/foreign from self, which is a fundamental feature of the adaptive immune 
system.  
 
1.1 The Thymus 
 
Concomitant with the emergence of the adaptive immune system and its T cell arm 
500 million years ago, a co-evolution of a specialized organ for T cell development 
took place, i.e. the thymus (2). T cell development is a non-autonomous process in 
which the thymus as a primary lymphoid organ provides the essential niches and 
constant signals for maturing T cells. The thymic stroma plays a key role at multiple 
stages of T cell development, on the one hand it ensures T cell lineage specification 
of common lymphoid precursors and on the other hand it is absolutely essential for 
MHC-self restriction via positive selection and the elimination of auto-reactive T cells 
via negative selection (3). Constituting the functional unit of the thymus, the thymic 
stroma consists of hematopoietic as well as non-hematopoietic components which 
are heterogeneous in their developmental origin, whereby dendritic cells (DC) and 
macrophages belong to the first group while epithelial cells and mesenchymal cells 
compose the latter. The postnatal thymus is compartmentalized into the inner 
morphologically lighter zone, the medulla, containing medullary thymic epithelial cells 
(mTEC), DC and macrophages and the outer morphologically darker zone, the 
cortex, mainly comprising cortical thymic epithelial cells (cTEC).  While the cortex is 
operative in positive selection, the medulla has been shown to crucially contribute to 
tolerance induction by expressing otherwise tissue-restricted antigens (TRA), thereby 
mirroring the peripheral self.   
 
1.1.1 Ontogenesis 
 
Thymus ontogenesis can be divided into pre- and post-thymus committed stages, 
whereby thymus specification is strictly linked to the expression of the transcription 
factor Forkhead box N1 (Foxn1) (4, 5). To date Foxn1 is the only marker that 
identifies early thymic epithelial cell commitment and its expression can be first 
detected around embryonic day 11.5 prior to vascularization and colonization by 
hematopoietic cells, indicating that early thymus development is a cell autonomous 
process or at least independent of hematopoietic cell immigrants (4, 6). Fate 
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mapping studies using Foxn1-Cre mice crossed to the Rosa26R-eYFP reporter 
system revealed that more or less all adult TEC have expressed Foxn1 at some point  
during development (7). The crucial role of Foxn1, not only as a marker but also 
functionally, has been unambiguously shown in Foxn1-deficient nude mice that 
exhibited a total block in early TEC development and consequently did not harbor 
any differentiation into cTEC and mTEC. Moreover, nude mice did not support any T 
cell development demonstrating the importance of a fully differentiated thymic 
epithelium for this process. A detailed analysis showed that the Foxn1-deficient 
thymus anlage did not express CCL25 and CXCL12 as well as Notch ligands, all 
absolutely required for T cell development (8, 9). Importantly, mixed chimera 
experiments established a cell autonomous role of Foxn1 in thymus development 
(10).  
TEC derive exclusively from the endodermal lining of the third pharyngeal pouch 
which was confirmed by grafting endoderm-only third pouch of day 9 mouse embryos 
into athymic mice and showing that this was sufficient to support T cell development 
(11, 12). In addition it was found that the neural crest-derived mesenchyme is crucial 
for early thymus organogenesis and thymus function (13). Factors that have been 
implied in thymus development prior to thymus specification are rare; Tbx1, a gene 
that has also been linked to the DiGeorge syndrome, was found to be essential for 
the formation of pharyngeal pouch-derived organs such as the thymus (14, 15). Of 
note, several other genes, like Hoxa3, Pax1 and Pax9, have also been shown to 
have functional roles in early thymus generation (16-19). 
The typical medullary-cortical structures first become apparent around E12, 
interestingly coinciding with the first hematopoietic cell immigration. It is well 
established that proper TEC development into medulla and cortex is dependent, at 
least during some stages of maturation, on “thymic cross talk” which describes the 
requirement of immature TEC to interact with T cells in order to differentiate into 
cTEC and mTEC (20). This is based on the observation that T cell-deficient mice did 
not show the typical thymic architecture and exhibited a disrupted medulla-cortex 
organization (21-23). This cross talk involves various crucial cell surface molecules 
and pathways all of which will be discussed later in this section.  
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1.1.2 Common TEC progenitor 
 
It had been a long standing issue whether cTEC and mTEC originate from a common 
progenitor. This idea first came up with the observation that rare TEC in the adult 
thymus simultaneously express cTEC and mTEC markers; keratin 8 (K8) is largely 
expressed by cTEC while keratin 5 (K5) is specific to mTEC, however a rare 
population of TECs in the adult thymus appears to be positive for both, thus possibly 
representing a bi-potential progenitor. This hypothesis was even bolstered by the 
finding that large clusters of K8+K5+ TEC accumulated in thymi of mice that showed a 
block in T cell development (24). An ensuing study proposed MTS24+ cells, a subset 
of K8+K5+ TEC, to fulfill the criteria for a common progenitor, however this has been 
disproven later (25-27).    
Today it is largely accepted that cTEC and mTEC both arise from the same 
progenitor which was convincingly proven by two independent studies. First, Foxn1-
reactivation in single TEC of a Foxn1-deficient adult thymus led to the generation of a 
fully competent thymus capable of supporting T cell development (7). Second, a 
single yellow fluorescent protein expressing keratin+ cell isolated from embryonic day 
12.5 murine thymi gave rise to both cTEC and mTEC clusters when placed into an 
embryonic thymus (28). While these studies clearly demonstrate the existence of a 
bi-potent TEC precursor, yet no specific marker for the identification of a common 
progenitor has been described.  
 
 
1.1.3 cTEC progenitor 
 
Whereas the last few years brought some insight into the mechanisms of TEC 
development, especially mTEC development, still very little is known about cTEC 
differentiation. Bleul et al. could prove the existence of a cTEC-committed progenitor 
by fate mapping experiments using a YFP reporter, however, no specific marker of 
early cTEC has been defined in this study (7). cTEC in contrast to mTEC appear to 
be a largely homogenous population and are generally recognized by the surface 
expression of EpCAM-1 and Ly51. Very recently a potential cTEC precursor was 
identified in the embryo which was characterized by the expression of EpCAM-1 and 
CD205 while being negative or low for MHCII and CD40 expression (29). Moreover 
this presumable cTEC progenitor was highly proliferative and independent of 
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crosstalk with thymocytes while later stages of cTEC differentiation were found to 
require the presence of T cells.   
 
1.1.4 mTEC progenitor 
 
The earliest mTEC-specific progenitor that has been identified to date is a subset of 
Claudin-3 and -4 expressing TEC, isolated from E13.5 embryonic thymi (30). These 
cells were found to exclusively give rise to mTEC and not to cTEC when mixed into 
RTOC and grafted into nude mice, whereas Claudin3/4 negative TEC showed both, 
cTEC and mTEC potential. This data is indicative of a very early mTEC specification 
during ontogeny. 
Based on the expression of CD80, MHCII and AIRE, mTEC can be subdivided into 
three major subsets: CD80-MHCII-AIRE- mTEC, CD80+MHCII+AIRE- mTEC and 
CD80+MHCII+AIRE+ mTEC, whereby promiscuous gene expression (pGE), i.e. the 
ectopic expression of otherwise tissue restricted genes, increases in the same order, 
being highest in AIRE+ mTEC. pGE, a phenomenon that has been shown to be 
essential for the establishment of central tolerance, is largely controlled by AIRE (31, 
32). Initially it was found that the human Autoimmune Polyendocrine Syndrome Type 
I (APS-1) was linked to a mutation in the AIRE gene. Soon after, AIRE-deficient mice 
were generated, shedding more light on how AIRE enables tolerance induction to 
TRA. The function and molecular mechanism of AIRE is described below. 
In the context of mTEC development there has been a long lasting debate whether 
AIRE-expressing mTEC represent the most mature or immature cell subset. Two 
models have been proposed: The progressive restriction model assumes that AIRE-
expressing mTEC are progenitor cells that still have features of multipotent stem cells 
and constantly minimize pGE as they mature (33). The second competing hypothesis 
is the terminal differentiation model which implies that progressive differentiation 
leads to increased pGE. A prerequisite for this of course is, that CD80-MHCII-AIRE- 
mTEC develop into CD80+MHCII+AIRE- and finally into CD80+MHCII-AIRE- mTEC. In 
the last few years there was evidence accumulating, strongly arguing for the terminal 
differentiation model. For example AIRE+ mTEC were found to be postmitotic and 
have an unexpectedly high turnover rate of 1 week which has been attributed to the 
pro-apoptotic function of AIRE (34, 35). The final prove was brought by reaggregate 
thymic organ culture (RTOC) experiments directly showing the progeny-precursor 
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relationship of CD80-MHCII-AIRE-, CD80+MHCII+AIRE- and CD80+MHCII+AIRE+ 
mTEC (Figure  1). 
While early TEC development (before thymus specification) is independent of 
hematopoietic immigrants, proper cTEC and mTEC development requires interaction 
with T cells. Several surface molecules and signaling pathways have been implicated 
in this process: The NF-κB pathway plays a fundamental role in mTEC development. 
Interfering with components of the NF-κB pathway by inactivation of the TNF 
receptor-associated factor TRAF6 or the NF-κB complex component RelB and NF-κB 
inducing kinase (NIK) severely disrupted mTEC development and medulla formation 
(36). The lack of a functional medulla led to an uncontrolled release of auto-reactive 
T cells to the periphery and consequently to the development of multiorgan 
autoimmunity. In the same line it was shown that receptors activating the NF-κB 
pathway, namely the receptor activator of nuclear factor-kappa B (RANK) and CD40, 
critically contribute to normal mTEC differentiation. RANK-ligand/RANK and CD40L-
ligand/CD40 interactions with T cells synergistically induce mTEC maturation in the 
adult thymus (37-39), whereas RANK signaling provided by CD3+CD4- lymphoid 
tissue inducer cells was essential and sufficient to support the maturation of mature 
AIRE+ mTEC in the fetal thymus (37).  
The lymphotoxin-β receptor (LTβ-R) has also been implicated to be important for 
mTEC development, however its role has been controversial. While the LTβ-R was 
initially described to directly regulate AIRE and TRA transcription, this observation 
was soon challenged by the report of Boehm et al. showing that LTβ-R, instead of 
regulating AIRE itself, contribute to mTEC development (40-42). This controversy 
notwithstanding, there seems to be a role for LTβ-R signaling in mTEC development, 
albeit not a very fundamental one. Finally there was a report proposing that cognate 
interactions between mTEC and auto-reactive CD4+ SP T cells crucially contribute to 
mTEC maintenance (43). 
Collectively these data imply that a common TEC progenitor, that is present 
throughout life, differentiates into a cTEC or mTEC-commited progenitor in order to 
finally form mature cTEC and mTEC lineages respectively. The specification of these 
two lineages seems to undergo T cell-dependent as well as –independent stages 
(Figure 1). 
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Figure 1 – TEC development. TEC development proceeds along several stages 
that are partially dependent on interactions with T cells. The thymus originates from 
the endodermal lining of the third pharyngeal pouch and gives rise to a common, bi-
potent TEC progenitor which branches into the cTEC and mTEC lineage 
respectively. The receptors and signaling molecules involved in various 
developmental stages as well as the surface markers identifying the state of maturity 
are indicated.  
 
1.1.5 The Autoimmune Regulator (AIRE) 
 
The discovery of AIRE and its important role in tolerance induction is based on the 
genetic analysis of the autoimmune syndrome APS-1. Compared to other 
autoimmune diseases, the underlying genetics of APS-1 is rather simple with almost 
all identified mutations located exclusively in the AIRE gene (44). AIRE expression is 
restricted to very few cell types, being almost exclusively expressed in mature mTEC 
and to much lesser degree in DC in the thymus (45). With the generation of AIRE-
deficient mice it finally became clear that AIRE is directly linked to central tolerance. 
Loss of AIRE expression led to the development of multiorgan autoimmunity with 
inflammatory infiltrates and autoantibody production, thus by and large recapitulating 
the disease pattern of APS-1 (46). These observations prompted the speculation that 
TRA expression might be controlled by AIRE and indeed detailed analysis of AIRE-
deficient mTEC revealed that hundreds if not thousands of promiscuously expressed 
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transcripts are regulated by AIRE, e.g. insulin, salivary protein 1 and fatty acid 
binding protein. Of note not all TRA are under the control of AIRE, examples of which 
are C-reactive protein or GAD67, implying a potential role for additional, yet unknown 
factors (32). 
The precise molecular mechanism of AIRE is still largely obscure. At first glance 
AIRE appears to be a classical transcription factor, however several findings hint at a 
broader function of AIRE. First, AIRE regulates the transcription of several thousand 
genes which is by far more than any other known transcription factor (32). Second, 
there appears to be an extremely high variability in the transcriptional footprint of 
AIRE between individual mTEC (47, 48). Third, the pattern of TRA transcription in 
mTEC differs from that in the respective tissue and beyond that it appears to be 
independent of the tissue-specific transcriptional regulators (49). Interestingly it was 
shown that transcriptional start sites can also differ in AIRE-dependent transcripts 
(49). Fourth, rather than qualitatively activating gene expression, AIRE quantitatively 
increases the level of transcription, thereby accentuating “transcriptional noise” (47, 
50). Fifth, AIRE-regulated genes appears to be clustered in the genome (32). 
Structural analysis of AIRE shed some light on how AIRE might exert its function. 
First, AIRE contains a SAND domain (Sp100 AIRE-1 NucP41/75 DEAF-1) that was 
suggested to be involved in DNA binding. But instead of a strong and specific binding 
to DNA, AIRE seemed to interact with DNA in a rather non-specific manner and no 
conserved DNA binding element has be identified (51). Second, the PHD finger 
(plant homeo domain), a typical protein-protein interaction site, was speculated to 
enable AIRE to interact with nucleosomal histones (52). In particular it was found that 
AIRE specifically binds to unmethylated lysin 4 histon 3 (K4m0H3), interestingly a 
marker for inactive regions. This might be operative in concentrating AIRE at 
transcriptionally inactive sites in order to activate transcription. A third important 
domain, the CARD domain (caspase recruitment domain), was shown to be a crucial 
protein interaction domain, which could for example serve as a site for interactions 
with other transcriptional regulators (53). Therefore the identification of potential 
interaction partners of AIRE has been of great interest to in order to understand its 
mode of action (Figure 2). 
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Figure 2 - Structural and functional domains of AIRE. AIRE contains three major 
domains, the caspase recruitment domain (CARD), Sp100 AIRE-1 NucP41/75 
DEAF-1 (SAND) and plant homeo domain (PHD). The proposed functions of the 
different domains are depicted. 
  
 
The first protein that was found to bind to AIRE was the ubiquitous transcriptional 
activator CREB binding protein (CBP), whereby CBP is translocated to the nucleus in 
an AIRE-dependent fashion (54). Another binding partner of AIRE is the DNA-
dependent protein kinase (DNA-PK) which was described to be activated by double-
stranded DNA breaks and to phosphorylate proteins that are involved in transcription 
such as Polymerase II (Pol II) (55). P-TEFb was a very promising candidate as it is 
involved in transcriptional elongation by helping Pol II to be released from the 
initiation complex (56). Interestingly, proteins involved in splicing have also been 
found to interact with AIRE. 
The question of how AIRE can activate such a large battery of transcripts is of central 
importance in tolerance. A model, albeit highly speculative, has been proposed in 
which AIRE first binds in a rather non-specific manner to CpG-rich promoter regions, 
thereby being recruited to a large number of loci. Furthermore, the predisposition of 
AIRE to interact with H3K4m0 would favor its recruitment to transcriptional inactive 
sites. At that point several, probably synergistic, activities might come into place. 
Being located to the DNA, AIRE might recruit several transcriptional activators like P-
TEFb and thereby help Pol II to disengage from the transcription initiation complex. 
Of note, it was found that a large number of inactive genes have a preformed 
initiation complex at their promoter regions that is however unable to be elongated. 
Finally AIRE could also interact with splicing factors in order to facilitate processing 
and export of transcripts (57). 
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The role of AIRE with respect to tolerance induction has been extensively explored. It 
is believed that the main role of AIRE is to ensure the deletion of TRA-reactive T cells 
which was confirmed by the detection of eye and stomach-specific T cell clones and 
auto-antibodies in AIRE-deficient mice (58, 59).  In the same line, negative selection 
was diminished in TCR/neo-self-antigen double transgenic mice in the absence of 
AIRE (35, 60, 61). Another potential mode of tolerance that might be influenced by 
AIRE is the induction of regulatory T cells (Treg). It was shown that AIRE+ mTEC are 
capable of directly inducing Treg in a TCR/neo-self-antigen transgenic mouse model 
(62). However, transplantation of WT and AIRE-deficient thymi into athymic mice did 
not rescue from autoimmunity which speaks in favor of a Treg-independent defect in 
tolerance (35).  In a similar vein crossing AIRE-deficient mice onto a Treg-deficient 
background did even deteriorate the clinical picture strongly arguing for a defect in 
negative selection. Finally AIRE was also proposed to play a role in the periphery 
where it was found to be expressed by very rare cells in the LN and spleen that also 
express TRA, although with limited diversity (63). To date the physiological relevance 
of this phenomenon is unclear. 
 
 
1.2 T cell development – thymic microenvironments 
 
Whereas most hematopoietic cell lineages undergo differentiation and maturation in 
the bone marrow, T cells develop in a specialized organ, the thymus. T cell 
development proceeds in a temporarily and spatially strictly controlled order which is 
dictated by the microenvironment provided by the thymic stroma. The journey 
through the thymus is a matter of surviving; developing T cells have to go through 
several checkpoints where they either die or pass on until they are released to join 
the peripheral T cell pool as mature T cells. Only those T cells bearing a functional 
TCR that is self-MHC restricted and able to interact with peptide-MHC (pMHC) 
complexes in a certain window of affinity and/or avidity will pass the first checkpoints, 
the so-called β-selection and positive selection which takes place in the thymic 
cortex. After the first selection process that is accompanied by a tremendous cell 
loss, T cells translocate to the medulla and undergo tolerance induction during which 
self-reactive T cells are deleted, leaving a fully tolerant T cell repertoire (3, 64, 65). 
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1.2.1 Early T cell development in the thymic cortex 
 
Thymus-resident T cell progenitors have no or only very limited self-renewing 
potential; thus, in order to generate new T lymphocytes throughout life, a continuous 
influx of bone marrow-derived hematopoietic progenitor cells from the blood is 
required (66, 67). The entry of early thymic progenitor cells into the thymus, a 
process that is thought to be a gated phenomenon, was suggested to happen 
through high endothelial venules (HEV) that are located at the cortico-medullary 
junction (68, 69). The mechanism of thymus homing is not completely understood, 
however the involvement of different adhesion molecules (P-selectin, VCAM-1, 
MadCAM-1, ICAM-1, laminin and fibronectin) and chemokines such as CXCL12, 
CCL21 and CCL25 has been proposed (8, 70-76).  
Classically, early T cell development is subdivided into four stages defined by the cell 
surface markers CD25 and CD44 and location of the cell within the cortex (77). The 
earliest T cell progenitors are found within the most immature subset of thymocyte 
precursors, the double negative (DN) 1 cells that lack CD4 and CD8 expression. 
Typically enriched in the perimedullary cortex, DN1 cells are characterized by the 
surface expression of CD44 and CD117 and the absence of CD24 and CD25 (78). 
Not yet being committed to the T cell lineage, Notch-1 was shown to provide a crucial 
signal for T lineage specification as deletion of Notch-1 led to a complete block in T 
cell development and ectopic differentiation of B cells in the thymus (79-82). The 
requirement for Notch-1 signaling will not be lost until TCR rearrangement is 
complete in later stages of development.  
Lasting up to two weeks in the DN1 stage until progressing to the DN2 stage, DN1 
cells have by far the longest single period of intrathymic residence during which they 
expand by about 1000 fold (83, 84). The proliferation and survival of developing T 
cells is absolutely dependent on interactions with thymic microenvironments. Even 
though the molecular mechanisms involved are not fully understood, the Wnt 
signaling pathway and Kit ligand (stem cell factor) seem to play a role in providing 
signals for proliferation (85-87).  
After this period of proliferation, cells differentiate into the more T cell-restricted DN2 
stage that is marked by the up-regulation of CD25 and accompanied by migration 
outwards into the inner cortex. Note worthy, it is here that recombination-activating 
protein (RAG) gene expression is up-regulated for the first time and the first 
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rearrangements in the TCRγ/δ gene loci appear, whereas TCRα/β loci genes are still 
not accessible at this stage leading to TCRγ/δ versus TCRα/β lineage divergence 
(88). IL-7 has been shown to be essential for TCRγ/δ locus accessibility. 
Furthermore, IL-7 is required for survival and expansion of DN2 cells, as has also 
been shown for Kit ligand provided by cTEC (89-92).  
The signals involved in emigration from the perimedullary cortex are largely obscure. 
CXCR4 mutant lymphocytes have been found to be blocked at the DN1 stage as a 
consequence of being unable to migrate into the central cortex (75). A prerequisite 
for directional cell migration is not only a polarizing signal, but also a substrate for cell 
adhesion. Much in contrast to conventional migration along an extracellular matrix, 
DN2 cells “crawl” along the stromal matrix involving VCAM-1 and E-cadherin on 
epithelial cells (73). It has been speculated that the need for direct interaction with 
thymic stromal cells might represent an intrathymic feedback loop controlling the size 
of the various differentiation stages of T cell development. Like DN1, DN2 
thymocytes still retain the potential to develop into non-T cell lineages, i.e. DC and 
NK cells; thus, Notch-1 signaling in DN2 cells triggered by its ligand Delta-like 4 on 
cortical epithelial cells is indispensible for further T lineage specification (93, 94).  
After a rather short residence time of about two days, DN2 cells precede their 
maturation and migrate into the outer cortex, where they enter the again two days 
lasting DN3 stage which is concurrent with the down-regulation of CD44 and CD117 
and a low rate of cell cycling (83). Key events at this stage are the opening of the 
TCRβ locus, presumably regulated by IL-7 signaling, and the recombination of the 
germ line encoded VDJ segments of the TCRβ  locus (95, 96). First D – J 
rearrangements take place on both alleles and subsequently the recombined DJ 
segments rearrange with the V segment forming the TCRβ chain. This second step 
however strictly underlies the so-called “allelic exclusion”, meaning only one allele 
will eventually complete TCRβ recombination (97, 98). Implicit in this process is the 
formation of the pre-TCR, a complex consisting of a TCRβ chain, a pre-TCRα chain, 
CD3δ, ε, γ and TCRζ, an event that is decisive for the fate of the individual cell (99, 
100). Pre-TCR formation is a key process in T cell development and represents the 
first checkpoint, known as β-selection, which ensures that only those T cells that 
have successfully rearranged their TCRβ gene segments and hence express a fully 
functional pre-TCR on their surface are permitted to survive and to undergo further 
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differentiation (101, 102). This is marked by proliferation, the up-regulation of the co-
receptors CD4 and CD8 and finally irreversible T lineage commitment (103-105) .  
The transition from CD4/CD8 double negative to double positive immature T cells is 
referred to as DN4 or pre-DP stage and coincides with the continued migration to the 
outermost cortex, the subcapsular zone, which is critically dependent on CCL25 
(106). It is here that rearrangement of the TCRα gene locus is initiated but only after 
a massive expansion of those cells carrying a functional pre-TCR took place (107). 
During the whole expansion phase, the Rag genes are turned off to prevent any 
premature rearrangements of the TCRα locus. The enlargement of the precursor 
pool makes sure that every TCRβ positive cell gives rise to numerous progeny cells, 
each of which able to independently rearrange their α-chain, thereby increasing the 
possibility to survive and more importantly the diversity of the α/β−T cell repertoire. 
 
 
1.2.2 Positive selection 
 
The second important checkpoint in T cell development, the so called positive 
selection, is reached when DN cells become DP and ensures the generation of a 
self-restricted TCR pool. Here for the first time the polarity of cell migration is 
changed and DP cells migrate inwards towards the medulla (108). This 
developmental stage is mainly characterized by the rearrangement of the TCRα-
locus and, albeit low level of TCRα-locus rearrangement is readily detected in DN4 
cells, full-scale α-locus rearrangement does not take place until the DP T cell stage.  
In contrast to β-selection that simply requires T cell intrinsic pre-TCR signaling, 
positive selection is strictly dependent on TCR-pMHC interaction between T cells and 
cTEC (109-111). Accordingly it is not sufficient to simply express a functional TCR 
consisting of a successfully rearranged β- and α-chain, but to generate a TCR that 
additionally recognizes self-peptide–MHC complexes (112). This phenomenon was 
termed “recognition of self” and was first described in F1 bone marrow chimeras 
revealing that T cells did only recognize antigen when presented by MHC of the 
same type as the bone marrow recipient (113). Direct proof followed with the 
generation of the first TCR transgenic mouse; T cells ectopically expressing a 
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rearranged TCR were only positively selected in a thymus of the same haplotype the 
TCR originated from in the first place. 
Intuitively one would expect  that the possibility of a T cell receptor to recognize MHC 
by chance is extremely low, therefore it was speculated that the TCR has developed 
an inherent propensity to bind MHC (114). In support of this notion it was shown that 
random combinations of TCR α and β chains or pre-positive selection TCR react with 
a surprisingly high frequency with MHC (115-117). In the same line it was found by 
studying the crystal structure of the TCR that the CDR1 and CDR2 loops encoded in 
the V region showed an intrinsic specificity for MHC (118).  
Despite this inherent specificity for MHC, the efficiency of generating a MHC-
restricted TCR is very low; thus, T cells are able to continuously rearrange their 
TCRα-locus, which is structured in a way that allows for multiple rearrangements on 
each allele, until they are positive selected.  However, DP T cells have only a certain 
amount of time, as they have a life span of only 3-4 days until they either have 
generated the right TCR or die. Several factors, such as RORγ and TCF-1, have 
been implicated in the regulation of survival during positive selection by up-regulating 
the anti-apoptotic factor Bcl-XL (119-121). Notwithstanding all these mechanisms to 
increase the possibility for a DP cell to be positively selected, most developing T cells 
do not pass this checkpoint and die through “death by neglect” (Figure 3). 
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Figure 3 – T cell development. Early T cell development in the thymus proceeds 
along several distinct stages marked by the differential expression of CD44, CD117, 
CD25, CD4 and CD8. Essential factors for differentiation are depicted. Developing T 
cells are passing three major checkpoints, β-selection, positive selection and 
negative selection, at which they either die or further differentiate.     
 
 
 
 
Cortical thymic epithelial cells play a central role in positive selection. Presenting self-
peptide-MHC complexes to developing T cells, cTEC select those TCR fulfilling the 
requirements for positive selection, thereby shaping the T cell repertoire towards self-
restriction. Considering the paradox that antigen recognition by DP T cells in the 
cortex can lead to positive selection and survival while the very same event in the 
medulla can trigger negative selection and cell death (see section on negative 
selection below), it is of great interest to identify the decisive factor(s) leading to 
these completely opposite outcomes. 
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One possibility implicates the T cell itself which might integrate signals differently 
depending on its differentiation stage. Changes in gene expression pattern might not 
only impinge on the acquisition of responses to new signals but also on the loss of 
response to former signals.  Indeed it was shown that the threshold to discriminate 
between a strong and a weak engagement of the TCR is actively altered in DP T 
cells as compared to mature T cells, whereby the latter completely lose their ability to 
respond to weak TCR-binders implying an intrinsic regulation of T cell sensitivity 
during development (122).The molecular mechanisms underlying this phenomenon 
are largely unknown. It has been postulated that the signaling molecules proximal of 
the TCR play a fundamental role by acting as signal integrators of activating and 
inhibiting signals. Precisely, the TCR threshold is fine-tuned by constant inhibition via 
dephosphorylation involving several phosphatases like SHP-2 and PTPN22, whereby 
their quantitative alteration can either increase the threshold of activation or turn the 
cell more sensitive to TCR engagement as in the case of DP T cells (123).  
A different way to explain the paradox of positive selection was the affinity and avidity 
models that were focusing on the TCR itself and its binding property to the pMHC 
complex. Supporting this, it was found that very low concentrations of an antigenic 
peptide could mediate survival and efficient positive selection, while high avidity 
interactions promoted cell death in fetal thymic organ cultures (FTOC) (111, 124). 
Whereas these studies are in support of the avidity model, others clearly speak in 
favor of the affinity hypothesis by showing that positive selection requires pMHC 
complexes with antagonist or partial agonist properties (125). Generally, whether the 
selecting peptide was related or not, affinity studies supported the idea that the TCR 
affinity for ligands mediating positive selection was much lower than for negative 
selection. 
Another mutually non-exclusive possibility was based on the assumption that 
peptides presented in the cortex possess unique features that are required for 
positive selection. This so-called “altered peptide hypothesis” suggests that there are 
different ligands presented by cTEC as compared to those presented in the medulla 
and in the periphery. Peptide elution studies, however, comparing cTEC and splenic 
APC did not reveal any major differences in the ligandome of these two cell types 
(126). In line with this, two other studies showed that even a drastically reduced 
ligandome, using single-ligand mouse or an H-2DM deficient mouse, was able to 
support the selection of a normal T-cell repertoire (127, 128). However, later it was 
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shown that positive selection by H-2DM-/- epithelium, bearing a limited peptide 
spectrum, was reduced threefold in the absence of negative selection by DC (129).  
Whereas most of these findings would rather argue against an altered peptide 
hypothesis, several studies clearly speak in favor of it, all implying a differential 
antigen processing in cTEC: It was found that the cTEC-specific endoprotease 
Cathepsin L was critical for a normal CD4+ SP T cell compartment, presumably by 
generating peptides for MHCII suitable for positive selection (130). Likewise, 
inactivation of the thymus specific serine protease TSSP lead to decreased positive 
selection of several transgenic TCRs (131). Furthermore, another study showed the 
importance of macroautophagy, a peptide degradation process, in the selection of 
the TCR repertoire as positive selection of several TCR transgenic T cells was 
altered in autophagy-deficient thymi (132). There are also some indications for a 
differential MHCI peptide generation in the cortex. Recently a cTEC-specific 
proteasome was identified which was shown to be absolutely essential for normal 
CD8 T cell development beyond the DP stage, again indicating a role for the 
generation of “altered peptides” in the cortex (133). 
 
 
1.2.3 CD4/CD8 lineage choice 
 
The next important step immediately following positively selection is the so-called 
CD4/CD8-lineage choice in which thymocytes either differentiate into MHCII-
restricted CD4 or MHCI-restricted CD8 single positive (SP) T cells. This decision-
making process, albeit not fully understood yet, has been subject of intense 
investigations. Based on the fact that the extracellular domain of CD4 can only bind 
to the invariant domain of MHCII and CD8 can only bind to MHCI, CD4 bearing T 
cells recognize antigen exclusively in the context of MHCII and vice versa (134, 135). 
Several classical and non-classical theoretical models have been proposed trying to 
explain how the T cell is able to sense whether it is MHCII- or MHCI-restricted: 
The classical models are either of stochastic or instructive nature and are built on the 
assumption that the termination of one or the other co-receptor irreversibly defines 
the lineage fate. While the stochastic selection model implies that CD4 or CD8 
termination occurs randomly and thymocytes either receive a second TCR rescue 
signal in case the right receptor was repressed or die (136, 137), the instructive 
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model suggests that the MHCII- and MHCI-restricted TCR signals are distinct from 
one another, with respect to the signal strength (138). Another classical instructive 
model is the duration-of-signal model which also comprises that the CD4/CD8 
lineage decision requires qualitatively different signals, however not the signal 
strength but the duration of the TCR signal determines the lineage choice (139). 
Accordingly, TCR signals of long duration terminate CD8 expression while short TCR 
signals terminate CD4 expression.  
In the end all three models have been contradicted by experimental observations, 
however the idea of the TCR signal duration as a major CD4/CD8 lineage 
determinant remains still valid today and is the central feature of the kinetic signaling 
model (140).  
With the finding that positively selected TCR-signaled DP T cells terminate CD8 
expression, it became clear that CD4+CD8low T cells are uncommitted and represent 
the immediate precursor of CD8 and CD4 SP T cells (141, 142). Consequently, 
MHCI-restricted signals are short natured whereas MHCII-restricted signals are long 
natured. Based on this, the kinetic signaling model suggests a scenario  in which the 
T cell senses changes in TCR signaling after CD8 down-regulation; if the T cell is 
MHCII-restricted and therefore CD4-dependent, the TCR signal will not alter after 
termination of CD8 and the cell will be deviated into the CD4 SP lineage, however if 
the T cell is MHCI-restricted and consequently dependent on CD8, the TCR signal 
will be weaker without CD8 expression, signaling the cell to differentiate into the CD8 
lineage.  
Of central importance in the process of CD4/CD8 lineage choice are IL-7 as well as 
several transcription factors. IL-7 was shown to be crucial for CD8 lineage choice as 
blockade of IL-7R signaling abrogated the termination of CD4 transcription and up-
regulation of CD8 transcription and hence CD8 lineage commitment (143). Recently 
a transcriptional network has been implicated in T lineage choice including the 
transcription factors ThPOK (T-helper-inducing POZ/Krueppel-like factor) and 
RUNX3 (Runt-related transcription factor). CD8 down-regulation is dependent on 
ThPOK and further it prevents RUNX3 from silencing the CD4 locus (144, 145). 
Moreover, TOX (Thymocyte selection-associated high mobility group box protein 
TOX) has been found to be responsible for maintaining or up-regulating CD4 
transcription in positively selected DP T cells and finally it was observed that GATA3 
blocks CD8 lineage differentiation while promoting CD4 lineage choice (146-149). 
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Intense studies in the last years have shed much light on the process of CD4/CD8 
lineage choice, however the exact sequence of events and the molecular players 
involved still remain to be determined (Figure 4).  
 
 
 
 
 
Figure 4 - Kinetic signaling model. Depicted are the three sequential steps in the 
CD4/CD8 lineage decision process. Surface molecules indicative of different 
maturation stages as well as factors necessary for CD4 or CD8 lineage choice are 
shown.   
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1.2.4 Central tolerance – a historical overview  
 
Early concepts of immunity date back to the beginning of the 20th century and the 
theory of Paul Ehrlich on antigen recognition. To enlighten the conundrum how the 
body can respond to an enormously wide range of pathogens, he proposed the “side-
chain theory”. He believed that every naturally occurring antigen can be recognized 
by at least one chemical side chain expressed on the surface of cells. A side chain 
can form a link with the appropriate antigen which leads to the production of high 
amounts of the very same chain and its secretion into the blood as an “antibody”.  
Ehrlich´s selective theory of antibody production had soon been challenged by the 
work of Karl Landsteiner and Merill Chase, showing that antibodies could be raised 
against any chemical structure – even synthetic structures.  Thus they introduced the 
“template instructive hypothesis” that dominated the first half of the 20th century. The 
common believe was that an antigen interacts with a globulin in the early stage of 
globulin formation and thereby helps to form a mature globulin molecule specific for 
the antigen. Even though this concept could explain how antibodies can be formed 
against any synthetic structure, it failed to account for the rapid rise in antibody 
production after immunization as well as the phenomenon of memory formation.  
Niels Jerne, in 1955, dealt with this problem. He picked up Ehrlich´s initial ideas and 
proposed the “natural selection theory” of antibody formation. According to his theory, 
an antigen binds to an antibody by chance, and triggers replication of the very same 
antibody (150).  
Jerne´s selection theory paved the way for Frank Macfarlane Burnett´s “clonal 
selection theory”, a seminal landmark modern immunology (150). While Jerne 
considered the antibody as the replicating unit, Burnett for the first time positioned 
the cell itself in the center of interest, being the replicating unit. According to this, 
antibodies would function as cell surface receptors that can eventually bind to an 
antigen, whereby the cell is activated and gives rise to numerous clones that 
massively produce and secrete antibodies of the very same specificity. Consequently 
the cell became the important unit being the selectable element in immunity. Burnett 
also solved the problem of memory formation as well as affinity maturation 
suggesting that mutations in the process of replication would eventually result in an 
increased affinity to a particular antigen. Most importantly he proposed a model for 
the phenomenon of tolerance, for which he together with Peter Medawar shared the 
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Nobel Prize for physiology and medicine in 1960 and which is, at least in part, still 
valid today (151). He was convinced that as a consequence of random antibody 
generation, the immune system had to be purged from auto-reactive cells during 
embryogenesis and early after birth when the cells are exclusively exposed to self 
antigens. 
It took over 20 years and great advances in cellular and molecular immunology until 
the paradigm of “developmental tolerance” was again disproven by the work of Nicole 
Le Dourain and colleagues. They found that embryonic tissues from quail engrafted 
into age-matched chickens were rejected soon after birth (152, 153) and importantly, 
this graft rejection could be prevented by solely transplanting thymic rudiments from 
the graft donor. This certainly highly unexpected finding revealed two important 
points: first, it was not sufficient to simply “see” antigen during embryogenesis in 
order to acquire self-tolerance and second, peripheral, tissue-specific tolerance was 
established by pure thymic epithelium that was completely devoid of hematopoietic 
cells. The mechanism of how thymic epithelium can induce tolerance to the whole 
spectrum of peripheral antigens was still not understood at that time. However, a few 
years later, in 1989 Linsk et al. proposed a model according to which the thymus 
represents a patch quilt of ectopically expressed genes (154). Direct proof followed 
with the finding that “promiscuous gene expression” (pGE) of tissue-restricted 
antigens (TRA) was a specific attribute of medullary thymic epithelial cells (mTEC) 
and that this phenomenon was largely regulated by AIRE (45, 46) and absolutely 
crucial for central tolerance. 
The mechanism of how self-reactive T cells are purged from the body became clear 
in the middle of the 80s when B and T cell receptors were discovered and the first T 
cell receptor transgenic mouse was generated, making it possible to follow and 
visualize T cells during development (155). Self-reactive T cells were found to be 
deleted upon antigen encounter in the thymus. However, in all these systems, 
deletion was rarely complete raising the question whether there might be additional 
mechanisms of tolerance.   
The missing link was provided a few years later by the identification of a T cell subset 
that was essential for the prevention of autoimmunity. Belonging to the CD4 T cell 
lineage, these cells expressed the high affinity interleukin-2 receptor and functioned 
by actively suppressing other potentially dangerous T cells (156-159). A new 
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mechanism of tolerance was finally established, termed dominant tolerance, which 
should dominate the field of immunology ever since. 
  
1.2.5 Negative selection 
 
Negative selection represents the third and last critical checkpoint during T cell 
development and is operative in removing potentially dangerous self-reactive T cells. 
Even though Le Dourain most convincingly established the importance of the thymus 
in central tolerance, the biological mechanism of how auto-reactive T cells are 
rendered innocuous was only speculative. Two scenarios were favored, proposing 
that potentially harmful T cells are either silenced by undergoing anergy or are 
purged from the repertoire by clonal deletion. The outstanding work of Marrack et al. 
finally shed more light on this issue by showing that T cells, that recognized antigen 
in the thymus were eliminated, a finding that was clearly in support of the clonal 
deletion model (160). It was found that T cells carrying the Vβ17a TCR chain were 
deleted in animals expressing superantigens derived from the mouse mammary 
tumor virus and presented in the context of I-E MHC molecules, while the same T 
cells normally matured and migrated to the periphery in the absence of 
superantigens.  Moreover, it became clear that there are various superantigens (Mtv-
8,-9) depending on the mouse strain that are recognized by particular Vβ segments 
(Vβ17a, Vβ5, Vβ11) (161, 162). 
Later, the clonal deletion model was further validated in numerous TCR transgenic 
mouse models expressing a receptor for a self antigen along with the self antigen. In 
most of these systems the antigen was transgenically expressed (e.g. Hemagglutinin, 
HA), in some others however TCR-transgenic mice were generated that recognized a 
naturally expressed antigen (e.g. H-Y) (reviewed in (3)). These mice provided an 
excellent tool for studying negative selection, with respect to the anatomical location, 
the relevant APC and the molecular signaling events involved. 
It has been a longstanding issue where and when self-reactive T cells are removed 
from the thymus. Intuitively, the medulla is the likely site for negative selection, as it 
provides the most complex ligandome. Unlike the cortex it is heavily colonized by 
hematopoietic APC, presumably carrying all kinds of peripheral blood-born antigens 
and furthermore, the medulla is composed of mTEC, providing a wide range of rare 
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tissue-restricted antigens. In the same line, clonal deletion most likely occurs rather 
late in T cell development as DN T cells not yet express an intact TCR which is 
prerequisite for negative selection. The problem appears, however, that the medulla 
contains mainly mature T cells that are resistant to negative selection; nevertheless it 
can be assumed that mature SP T cells upon migration to the medulla remain 
susceptible to deletion for a certain time span. Indeed it was found that the medulla 
contains a substantial fraction of semi-mature, HSAhigh CD4+ SP T cells that were still 
sensitive to tolerance induction (163).  
The process of negative selection was found to be remarkably efficient, as already 
minute amounts of DC were sufficient to switch from no deletion to full scale deletion 
of polyclonal T cells in an in vitro RTOC system (64, 164). Ligands inducing negative 
selection are unlike positively selecting ligands highly stimulatory to mature T cells. 
Thus negative selection of T cells is generally initiated by high affinity pMHC-TCR 
interactions that induce strong signaling through the TCR, albeit TCR triggering alone 
was shown to be insufficient for negative selection. Several co-stimulatory cell 
surface molecules have been described to play a role in the induction of negative 
selection; among these are CD28, CD5, CD43 and Fas (165, 166). In addition it was 
found that mice deficient for the co-stimulatory receptor CD40 were also found to be 
impaired in negative selection (167).  
Even though the proximal TCR signaling events overall appear to be similar in 
positive and negative selection, some molecules have been uniquely attributed to 
negative selection (3). In particular the mitogen activated protein kinase (MAPK) 
family members Jun N-terminal kinase (JNK) and p38 are central players in the 
initiation of negative selection as deficiency in either one of these pathways leads to 
defective induction of apoptosis in self-reactive T cells (168). Early TCR proximal 
signaling events involved the adaptor protein Grb-2 which recruits the Ras-activator 
SOS1 to the membrane and ultimately leads to the activation the JNK/p38 pathways 
(168).  Recently another important activator of the JNK/p38 kinases, the Misshapen-
Nck-interacting kinase-related kinase (MINK), has been identified to play a 
fundamental role in negative selection (169).  Its expression is highly regulated in T 
cell development, being low in DN and strongly up-regulated in DP thymocytes. 
Accordingly, knock down of MINK had no effect on positive selection, while it 
specifically interfered with negative selection by crippling the apoptosis pathway 
(170).  
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Apoptosis has a central function in tolerance induction by being essential for the 
deletion of auto-reactive T cells. The executor molecules in this process are primarily 
members of the Bcl-2 family, like BIM as well as Bax and Bak that are pro-apoptotic 
family members. Accordingly, deficiency of BIM as well as combined deficiency of its 
down-stream effectors Bax and Bak hampered negative selection (170, 171). 
Furthermore, it was shown that BIM activation crucially depends on the JNK and p38 
kinase pathways, whereby expression of BIM is directly regulated by the transcription 
factor Nur77 which belongs to the orphan steroid receptor family. Interestingly, in 
addition to its function as a transcription factor, Nur77 has been found to directly bind 
to the anti-apoptotic factor Bcl-2, thereby converting it into a pro-apoptotic molecule. 
Thus in the presence of Nur77, Bcl-2 is unable to inhibit BIM (172). 
Taken together, negative selection involves several, in part synergistic events 
including the activation of the JNK/p38 pathways by Grb-2 and MINK, which in turn 
leads to the induction of the pro-apoptotic factors BIM, Bax and Bak. Furthermore, 
besides activating BIM expression, Nur77 inhibits the anti-apoptotic molecule Bcl-2 
ultimately leading to induced cell death which is the basis of negative selection. 
 
 
1.2.6 Dominant tolerance - Regulatory T cells  
 
Ever since its discovery, negative selection was proposed to be the ultimate 
mechanism mediating central tolerance. However, in the middle of the 90s it became 
clear that an additional branch exists, representing a yet unknown mode of tolerance, 
the so-called dominant tolerance. This was based on the observation that the 
process of negative selection in the thymus is incomplete as the normal immune 
system harbors T cells that are self-reactive and even capable of inducing 
autoimmune disease. Consistent with the notion that auto-reactive T cells are present 
in the periphery, a subset of CD4+ T cells expressing the IL-2 high affinity receptor 
CD25 was found to suppress the activation and expansion of these potentially 
hazardous cells and therefore crucially contribute to the prevention of autoimmunity 
(173).  
Evidence for dominant tolerance came from experiments showing that neonatal 
thymectomy between day 2 and 4 after birth led to severe autoimmunity (174, 175). 
Soon after, more light was shed on this observation by identifying the regulatory cell 
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subset responsible for this phenomenon. Transfer of splenic T cells depleted of 
CD4+CD25+ T cells and injected into athymic mice was shown to be sufficient to 
induce autoimmune disease. Importantly the transfer of CD25+ together with CD25- 
CD4+ T cells completely prevented disease development. Thus it was thereon 
accepted that CD4+CD25+ regulatory T cells (Treg) are crucial mediators of tolerance 
by keeping auto-reactive T cells under control (176).  
Treg share many hallmarks with conventional activated T cells, e.g. CD25, PD-1, 
GITR and CTLR-4, which makes their reliable identification very difficult. With the 
discovery of the transcription factor Foxp3 (Forkhead Box protein P3) a true marker 
and moreover a master regulator of Treg was finally found (177-179). Foxp3 was first 
identified in the “scurfy” mouse mutant strain that suffered from severe autoimmune 
manifestations that were caused by a complete lack of Treg. Detailed analysis 
revealed that Foxp3 is essential for the development of Treg by amplifying already 
established features of Treg precursors in the thymus and furthermore, it was shown 
to be indispensible for the function and maintenance of Treg (180-182). 
It is well established that the induction of autoimmunity is driven by the recognition of 
self constituents by naive T cells in the periphery. In healthy animals these potentially 
harmful T cells that have escaped negative selection in the thymus are controlled and 
suppressed by Treg. This raised the question whether Treg might overlap with auto-
reactive T cells with respect to their TCR specificities, implying that Treg development 
might also depend on tolerogenic interactions with self–antigens. Evidence for an 
affinity model of Treg development came from TCR transgenic mouse models 
showing that the expression of a cognate antigen in the thymus could lead to the 
development of TCR transgenic Treg specific for the antigen (183, 184). Thus it was 
believed that the increased affinity of a given TCR to a self-peptide-MHC complex 
would favor the induction of Treg. In a polyclonal system the requirement of self-
peptide for Treg development is difficult to prove as it is not feasible to trace the fate of 
individual T cells carrying a specific TCR. Studies analyzing the diversity of the TCR 
repertoire, however, yielded some interesting insights concerning the TCR specificity 
of Treg. Using a TCRβ transgenic mouse with a single copy of a TCRα minilocus, the 
variability of the α-chain could be determined. Vα2-containing variable regions of the 
naïve versus the regulatory thymic and peripheral T cell pool were sequenced and 
compared to each other (185, 186). Strikingly, the repertoire of the two pools was 
highly distinct and only partially overlapping whereas the diversity was comparable. 
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Of note, there was a high similarity between thymic and peripheral Treg as was the 
case for thymic and peripheral naïve T cells, again suggesting that the majority of Treg 
arise in the thymus. 
TCR signaling is essential but not alone sufficient for the development of regulatory T 
cells. Cytokine signaling and co-receptor signaling were found to crucially contribute 
to this process.  Studies interfering with cytokine signaling by either making use of a 
common γ chain-deficient or a STAT5-deficient mouse revealed an importance of 
these pathways for Treg generation (187-189). Attempts to nail down a particular 
cytokine crucial for this process failed. Neither IL-2 nor IL-15 alone was required for 
the generation of Treg in the thymus, albeit IL-2 was found to be essential for the 
maintenance and survival of Treg in the periphery (187, 190).  Thus it is currently 
unknown whether a single cytokine or a combination of several common γ chain 
cytokines, acting in a redundant manner, is essential for the development of Treg. 
Furthermore, interference with TGFβ signaling demonstrated a requirement of TGFβ 
in the first wave of Treg induction, a requirement that is later compensated for by IL-2 
(191). Finally CD28-B7 signaling plays a central role for the development of Treg. 
CD28-deficient mice have a strongly reduced Treg compartment in the thymus which 
was not a consequence of a lack of soluble factors like IL-2 but of a defective in the T 
cell intrinsic program induced by CD28 itself (192, 193). 
In summary, the initiative step in Treg development seems to be high affinity 
interactions with self-peptide-MHC complexes, whereby cytokines and co-receptor 
signaling support this differentiation process. How Treg are rescued from negative 
selection and what particular features of APC are needed for Treg induction is still 
poorly understood. A recent study was addressing this question and found that Treg 
differentiation does not require a particular APC but instead underlies an intrinsically 
regulated mechanism whereas the capacity to differentiate into Treg inversely 
correlates with the maturation status of the T cell (194). However, if there is an 
optimal window of avidity that favors Treg induction which is lower than the avidity 
required for negative selection is still unknown and will be a prospect of this study.  
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1.2.7 Antigen presentation in the medulla 
 
To understand how central tolerance is maintained and how different modes of 
tolerance are induced, it is indispensable to get a detailed picture of the different APC 
in the medulla and their specific properties regarding antigen presentation. Tolerance 
induction occurs mainly in the medulla which consists of two types of APC, namely 
mTEC and DC. DC are a rather heterogeneous population containing CD11cint 
plasmacytoid DC (pDC) and CD11chigh conventional DC (cDC) that can be further 
subdivided according to SIRPα expression (195). SIRPα- cDC were found to 
originate in the thymus, while about one third of cDC, characterized by the presence 
of SIRPα, are immigrants from peripheral sites (196-198). Of note, pDC are also 
highly abundant in the thymus, however, their function has yet to be established.  
In general DC in the thymus were unambiguously shown to be of central importance 
for tolerance induction (199, 200). Accordingly, DC-deficient mice developed 
multiorgan autoimmune disease and moreover diminished negative selection of bulk 
polyclonal CD4+SP T cells was observed in mice deficient of antigen presentation by 
DC (201, 202). In addition to that, an indispensible role of DC in negative selection 
was also confirmed in a TCR-transgenic mouse models of deletion (203). Another 
remarkable feature of DC in the thymus is their ability to efficiently take up and 
present extracellular antigens (204-206). Consistent with this notion, it was found that 
a neo-self antigen that was expressed only by mTEC could lead to the deletion of T 
cells carrying the respective TCR in a DC-dependant manner (203). More 
importantly, even TRA expressed by mTEC were shown to be transferred to and 
presented by DC in the thymus (207). In contrast to previous assumptions, terminally 
differentiated mTEC, possibly through the proapoptotic function of AIRE, have a very 
high turn over rate of 1 – 2 weeks (34, 208). Considering the fact that only about 1-
3% of mTEC express a given TRA, dying mTEC may therefore substantially 
contribute to antigen spreading to DC which might be a mechanism to increase the 
efficacy of tolerance induction (209).  
The central question therefore is whether mTEC solely serve as an antigen reservoir 
which would support a “division of labor” model of tolerance induction by DC and 
mTEC or whether mTEC themselves have a function as antigen presenters. Several 
observations, however, strongly speak in favor of an autonomous role of mTEC as 
APC.  
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First, mTEC are besides cTEC the only non-hematopoietic cells that constitutively 
express MHCII and a range of co-stimulatory molecules such as CD80 upon 
maturation, therefore being perfectly equipped for tolerance induction (209). Second, 
it was recently shown that developing T cells in the medulla engage multiple short-
lived interactions with APC, thereby probably thoroughly scanning their environment 
for self antigens (210). Thus, despite the relatively low percentage of mTEC 
expressing a given TRA, it would still be feasible that mTEC themselves induce 
tolerance, considering the long residence time of 4 – 5 days until CD4+ SP T cells 
leave the medulla. Third, mTEC have been shown to be poor in antigen uptake from 
the extracellular space, indicating that they probably focus on their intracellular milieu 
for antigen presentation and in that way presumably enhance tolerance induction to 
TRA (205). Interestingly it was found that mTEC indeed use an unconventional 
MHCII loading pathway termed macroautophagy. In this study it was proposed that 
macroautophagy is shaping the CD4 T cell repertoire by biasing the MHCII 
ligandome of mTEC on their intracellular compartment. Consistent with this 
assumption, macroautophagy-deficient mice developed severe autoimmune disease 
(132). Forth, Gallegos et al. convincingly proved that mTEC autonomously induced 
the deletion of CD8+ T cells specific for a neo-self antigen that was expressed in a 
promiscuous fashion (203). Moreover, in support of an independent role of mTEC as 
APC it was shown that mTEC-specific expression of hemagglutinin (HA) led to the 
induction of HA-specific CD4+ Treg in a cell autonomous, DC-independent manner 
(62). These results, however, have to be interpreted with caution. Recently it was 
found that even intact peptide-MHC (pMHC) complexes can be transferred from 
mTEC to DC (207, 211), which was never taken into account when MHC-deficient 
bone marrow chimeras were used to prove the autonomous role of mTEC in 
tolerance induction. 
Collectively, in addition to antigen presentation by mTEC themselves, antigens can 
efficiently spread in the thymic medulla, whereby mTEC-derived self antigens may be 
transferred to and presented by DC. This process does not only seem to involve 
conventional pathways of antigen spreading but also the intercellular transfer of 
functional MHC molecules and other TEC-specific membrane proteins. Finally 
antigen presentation by mTEC and DC might not differ with respect to the mode of 
tolerance that is induced but with respect to the selection of antigens that are 
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presented by a particular APC, e.g. TRA, soluble or peripheral antigens, thereby 
autonomously shaping the TCR repertoire (Figure 5). 
 
 
 
 
 
Figure 5 - Antigen presentation by medullary APC. This is a model of how self-
reactive T cells might recognize antigen in the medulla. Tissue restricted antigens 
(TRA) are produced by mTEC in an AIRE–dependent manner and subsequently 
loaded on MHC molecules which might be enhanced by macroautophagy. 
Furthermore, TRA can also be transferred to and presented by DC, thereby possibly 
increasing the efficiency of tolerance induction to rare tissue restricted antigens. In 
addition, migratory DC might provide antigen from peripheral sites.   
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2. AIM OF THE STUDY 
 
The ectopic transcription of thousands of tissue restricted antigens (TRA) is a 
fundamental hallmark of medullary thymic epithelial cells (mTEC) and is 
indispensable for tolerance induction in the thymus (33, 45). This phenomenon, 
termed promiscuous gene expression (pGE), is largely controlled by the autoimmune 
regulator (AIRE) and genetic ablation of AIRE has been shown to lead to multi-organ 
autoimmune disease. Thus, mTEC inarguably represent an essential source of 
peripheral tissue antigens for central tolerance. However, it is less clear whether 
mTEC, beside antigen production, also serve an important role in antigen 
presentation and direct tolerance induction of T cells, in particular for CD4+ T cell 
tolerance.  
Aim of this study was to address this issue by interfering with MHCII-restricted 
antigen presentation directly and only in mTEC. In order to do so we chose an RNA 
interference (RNAi) approach to tissue-specifically knock-down the Class 2 
transactivator (C2TA), the master regulator of MHCII expression. Selecting C2TA 
instead of directly targeting MHCII enabled us to study antigen presentation by 
mTEC irrespective of the mouse background. In this model we aimed to assess the 
consequence of impaired antigen presentation by mTEC on tolerance induction of 
polyclonal as well as of TCR-transgenic CD4+ T cells. 
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3. RESULTS 
 
3.1 Cloning and in vitro evaluation of C2TA-designer miRNA  
 
It has been previously published that a short hairpin that is integrated into the human 
miRNA30 backbone can be used to obtain knock-down of any gene of interest (212). 
Importantly, in contrast to conventional short hairpins, transcription was strictly 
dependent on Polymerase II, which enables tissue-specific knock-down of the gene. 
We took advantage of this new approach and generated five predicted designer 
miRNA against C2TA, the master-regulator of MHCII expression. In order to identify 
functional miRNA30-based C2TAsh constructs, the MHCII+ B cell line WEHI279.1 
was infected with a retroviral vector expressing the different C2TAsh constructs and 
MHCII down-regulation of stable B cell clones was monitored. Figure 6A shows the 
most potent C2TAsh construct that was henceforth used in all experiments. 
C2TAsh#6 most strongly down-modulated MHCII mRNA expression (Figure 6B) and 
protein level (Figure 6C).  
The functional consequence of MHCII down-modulation was tested via an antigen 
presenation assay using the A5 T cell hybridoma expressing the clonotypic TCR 
specific for HA(107-119) and GFP under the contol of IL-2 promoter elements. The 
results revealed a  more than five fold difference in T cell stimulation capacity of 
C2TA knock-down B cells as compared to control-infected B cells when increasing 
amounts of petide were added to the co-cultures (Figure 6D).   
 
 
 
 
 
 
A 
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igure 6 – Determination of knock-down efficiency of C2TA-specific designer 
C 
 
F
miRNA in vitro. (A) Scheme of the retroviral vector (LMP) containing the C2TAsh#6. 
The LMP vector used for screening of C2TAsh constructs contained 5´ and 3´ 
regions of the primary human miRNA30 as well as the selection marker puromycin 
and GFP. (B) Quantitative analysis of MHCII mRNA of control and C2TAsh#6 
infected B cells using real time PCR (n=3). (C) Quantification of MHCII protein levels 
of control and C2TAsh#6 infected B cells by FACS and western blot analysis (n=3). 
(D) Assessment of antigen presentation capacity. Control or C2TAsh#6 infected B 
cells were co-cultured with A5 hybridoma T cells in the presence of increasing 
amounts of HA peptide. After 19h GFP expression of hybridoma T cells was 
determined by FACS analysis. 
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3.2 Generation of mTEC-specific C2TA knockdown mouse 
o address the role of antigen presentation by mTEC in tolerance induction of CD4+ 
attern of the miRNA30-C2TAsh#6 transgene was analyzed. To 
ntify the impact of the miRNA30-C2TAsh#6 transgene 
 
T
T cells, we generated an mTEC-specific C2TA knock-down mouse (C2TAkd). A 
bacterial artificial chromosome transgenic construct containing 152kb upstream and 
58kb downstream flanking regions of AIRE was cloned, in which the AIRE start 
codon was replaced by an open reading frame encoding the miRNA30-C2TAsh#6 
construct (Figure 7A). Pronuclear injection of fertilized eggs resulted in the 
generation of two founder lines, both showing similar phenotypes in preliminary 
analyses (data not shown). One founder, termed C2TAkd, was used to perform all 
further experiments.  
First the expression p
this end, various thymic stromal cell subsets were purified from C2TAkd animals and 
relative expression was determined using a custom small RNATaqMan assay. 
Expression of the C2TAmiRNA was exclusively restricted to mTEC, whereby 
CD80hiAIRE+ mTEC (mTEChi AIRE+) showed the highest level of the C2TA miRNA, 
followed by CD80hiAIRE- mTEC (mTEC AIRE-)(Figure 7B). Signals derived from 
cTEC as well as DC were below the sensitivity of the assay. These data established 
that the transgene was faithfully expressed, mirroring the endogenous AIRE 
expression (Figure 7C).  
Next we aimed to qua
expression on C2TA as well as on MHCII mRNA levels in all mTEC subsets. MHCII 
expression was strongly down-regulated in CD80hiAIRE+ mTEC (mTEChi AIRE+) and 
to lesser extend in CD80hiAIRE- mTEC (mTEChi AIRE-) and CD80- mTEC (mTEClo). 
The same was found for C2TA expression itself, although the degree of down-
modulation was lower, implying that both translational and transcriptional silencing of 
C2TA was induced by the C2TA miRNA (Figure 7D). Importantly, MHCI expression 
which was shown to be slightly activated by C2TA (213, 214) was not altered in 
C2TAkd animals as compared to WT. The results confirmed highly specific and 
efficient C2TA knockdown in C2TAkd mice, being exclusively restricted to mTEC and 
most distinct in mature mTEC.  
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Figure 7 – Generation of C2TAkd mouse and analysis of transgene expression. 
(A) Schematic illustration of transgenic construct. The scheme shows the bacterial 
artificial chromosome construct containing 152kb upstream and 58kb downstream of 
the transcriptional start site of AIRE. The AIRE start codon is replaced by an open 
reading frame encoding the microRNA30-C2TAsh#6 construct cloned downstream of 
the β globin intron. (B) Expression analysis of the C2TA miRNA. Quantification of the 
C2TA miRNA in different stromal cell types (mTEChiAIRE+, mTEChiAIRE-, mTEClo, 
cTEC and DC) isolated from 2-3-weeks-old C2TAkd mice is depicted in the graph 
(n=3). (C) The graph shows the relative expression of AIRE mRNA in mTEChiAIRE+, 
mTEChiAIRE-, mTEClo and DC from 5 weeks old C2TAkd animals (n=3). (D) 
Determination of knockdown efficiency. C2TA mRNA levels in mTEChiAIRE+, 
mTEChiAIRE-, mTEClo from 5-weeks-old C2TAkd mice compared to WT was 
determined by real time PCR. Relative MHCII and MHCI expression in mTEChiAIRE+, 
mTEChiAIRE-, mTEClo form 5-weeks-old C2TAkd and WT animals is depicted in the 
graph (n=3). 
 
 
 
 
3.3 C2TAkd mice show highly specific and efficient down-modulation of MHCII 
 
Next the efficiency and tissue specificity of MHCII protein down-regulation in C2TAkd 
animals was assessed. Western blot analysis of highly purified thymic stromal cell 
populations confirmed a strong reduction of MHCII on the protein level in mature 
C2TAkd mTEC (mTEChi), whereas no alteration was seen in C2TAkd DC. Immature 
mTEC (mTEClo) isolated from C2TAkd mice were also found to reduce MHCII protein 
levels as compared to WT. Calculations of the relative changes in MHCII protein 
levels showed a more than tenfold reduction of MHCII in mature mTEC (Figure 8A).   
In addition to that, we performed flow cytometric analysis of MHCII of all major thymic 
stromal cell subsets, namely Sirpα- and Sirpα+ cDC, pDC, cTEC, immature and 
mature mTEC. The results revealed a remarkable reduction of MHCII protein 
exclusively in mTEC of C2TAkd animals but not in any other stromal cell types 
analyzed (Figure 8B).    
 
40 
 
  
 
A 
B 
 
Figure 8 – Determination of C2TA knock-down efficiency and specificity in 
C2TAkd mice. (A) Immature CD80lo and mature CD80hi mTEC as well as DC were 
purified from thymic stroma of 5–6-weeks-old WT or C2TAkd mice. Knockdown 
specificity and efficiency was assessed by western blot analysis of MHCII (upper left) 
(n=2). Relative quantification of MHCII protein level is depicted in the upper right 
panel. (B) MHCII expression by different thymic stroma cell populations of WT, 
C2TAkd and C2TA-/-thymi was determined by FACS analysis (n=3).   
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3.4 Diminished MHCII expression does not affect thymus integrity 
 
A recent study proposed a crucial role of MHCII in mTEC development or 
maintenance (43). Therefore we carefully analyzed the overall integrity of C2TAkd 
thymi by staining sections with different TEC markers (Figure 9). Medullae as well as 
cortico-medullary junctions were properly formed in C2TAkd animals. Similarly, 
AIRE+ mature mTEC were also normally abundant. MHCII stainings of WT thymi 
showed a strong positive signal in the medulla which is in accordance with an earlier 
study that reported a predominance of mTEC-derived cytoplasmatic MHCII signal in 
the thymic medulla (215). By contrast, C2TAkd sections stained only weakly for 
MHCII, whereby residual MHCII expression most likely derived from DC.  
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Figure 9 – Examination of medulla-cortex formation in C2TAkd mice. Depicted 
are stainings of cryosections from thymi of 6-weeks-old WT and C2TAkd mice for 
Keratin 5 (K5, green) and Keratin 8 (K8, red) to identify medulla and cortex (upper 
row). Middle and bottom rows show in situ detection of AIRE+ (red) or MHCII+ (red) 
cells in WT versus C2TAkd medullary areas (K5, green) (n=3). Scale bars are 
indicated. 
 
 
3.5 Normal mTEC development in C2TAkd animals 
 
Detailed flow cytometric analysis revealed no changes in the composition of mTEC 
subpopulations. About one fourth of all WT as well as C2TAkd mTEC expressed 
AIRE (24.2 ± 4.6 (n = 25) versus 22.2 ± 4 (n = 11); P = 0.19), the same hold true for 
CD80, albeit expression was slightly reduced in C2TAkd mTEC as compared to WT 
controls (60.8 ± 7 (n = 33) versus 55.8 ± 5 (n = 22); P = 0.004) (Figure 10A and 10B). 
Overall, mTEC development did not seem to be affected in C2TAkd mice, which 
therefore indicates a negligible role of MHCII in this process. 
To test the antigen presentation ability of C2TAkd and WT mice, mTEC were sorted 
and co-cultured with A5 GFP reporter hybridoma T cells recognizing HA(107-119) in 
the context of I-Ed. C2TAkd mTEC required at least ten times more peptide in order 
to have the same stimulatory effect on T cells as WT mTEC (Figure 10C).  Taken 
together these results established that mTEC development and maintenance is 
normal in C2TAkd mice, while antigen presentation capacity is strongly diminished. 
  
A C 
B 
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Figure 10 - Characterization of mTEC properties in C2TAkd mice. (A) The plots 
olated from 5–6-weeks-old WT or C2TAkd animals for 
MHCII and CD80. (B) The histograms show Aire-GFP expression in mTEC of WT x 
Aire-GFP and C2TAkd x Aire-GFP mice as well as Aire protein quantification of 
C2TAkd mTEC versus WT mTEC by WB analysis. Numbers indicate the average 
frequency (± s.d.) of cells within the gates. (C) Antigen presentation capacity of 
C2TAkd mTEC. Ex-vivo isolated mTEC from WT or C2TAkd animals were co-
cultured with A5 hybridoma T cells in the presence of increasing amounts of HA 
peptide. After 19h GFP expression of hybridoma T cells was determined by FACS 
is. 
 
 
3.6 Defective negative selection of polyclonal CD4+ SP T cells in C2TAkd mice 
 
 order to assess the co equence of diminished MHCII expression in mTEC on 
tolerance induction of CD4  T cells, bulk T cell development was analyzed. The CD4 
and CD8 profile of C2TAkd thymi revealed a significant increase in the CD4+ SP T 
cell compartment (9.0 ± 1.7 (n = 10) versus 12.1 ± 1.7 (n = 9); P =  0.001) while the 
CD8+ SP T cell compartment was essentially unaltered compared to WT thymi 
(Figure 11). These observations are reminiscent of earlier studies investigating the 
role of DC in negative selection and showing that the absence of antigen 
presentation by DC resulted in an enlarged CD4+ SP compartment, presumably due 
to reduced deletion of auto-reactive T cells (201, 202). Accordingly, our results 
support the notion that mTEC play a non-redundant role as antigen presenting cells 
(APC) in negative selection of CD4+ T cells.  
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Figure 11 – Selection of CD4+ and CD8+ T cells in C2TAkd thymi. CD4 and CD8 
stainings of thymocytes from 5-months-old WT and C2TAkd mice (left panel) (n=9). 
Average percentages of CD4 positive cells are indicated (± s.d.). The bar diagram 
depicts the relative distribution of different thymic T cell subsets of WT and C2TAkd 
mice respectively (right panel). P values are indicated.  
 
3.7 A non-redundant role of mTEC and DC in negative selection 
 
To address the contribution of DC versus mTEC in CD4 T cell tolerance induction in 
re generated. Irradiated WT recipients 
 
 the thymus. Likewise, to ascertain the impact of antigen presentation by mTEC, 
ntly also imply that these cells have an 
uto-reactive potential. To test this hypothesis, an in vitro proliferation assay was 
erformed using peripheral lymph node (LN) DC from WT animals as APC and CD4+ 
SP T cells from the above described bone marrow chimeras as responders. The 
results demonstrated that CD4+ SP T cells derived from thymi either devoid of 
antigen presentation by DC or mTEC or both contain a fraction of cells recognizing 
self-peptide MHC complexes (Figure 12B). Of note, again an additive effect was 
observed when both, DC and mTEC were unable to present antigen. 
Importantly, we did not find any significant changes in Treg development with respect 
to the overall size of the Foxp3+ compartment (Figure 12C). However, it is still 
repertoire of the Treg pool might be altered and some TCR 
specificities might therefore be missing in C2TAkd mice.       
detail, different bone marrow chimeras we
were reconstituted with MHCII-/- bm resulting in the inability of DC to present antigen
in
irradiated C2TAkd recipients were reconstituted with WT bone marrow. In both types 
of chimeras, an enlargement of the CD4+ SP T cell compartment could be observed 
(8.5 ± 0.3 (n = 9) versus 12.1 ± 0.1 (n = 7), P = 0.0006 and 8.5 ± 0.3 (n = 9) versus 
10.3 ± 0.3 (n = 10), P = 0.002) (Figure 12A). Importantly, an additive effect was found 
when both DC and mTEC were unable to present antigen to CD4+ T cells in C2TAkd 
animals that were reconstituted with MHCII-/- bone marrow (12.1 ± 0.1 (n = 7) versus 
15.2 ± 0.7 (n = 9), P = 0.01).  Taken together, these observations speak in favor of a 
non-redundant role of both DC and mTEC in negative selection by autonomous 
presentation of antigens to CD4+ T cells.  
The assumption that the increased proportion of CD4+ SP T cells is caused by 
defective negative selection would conseque
a
p
possible that the TCR 
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Figure 12 – CD4+ T cell selection by DC versus mTEC. (A) CD4+ T cell 
development in WT or C2TAkd recipients of WT or MHCII-/- bone marrow. The plots 
depict CD4 and CD8 profiles of WT or C2TAkd animals reconstituted with WT bone 
marrow and analyzed 6 weeks later (upper left panel). Lower left panel, WT or 
C2TAkd animals reconstituted with MHCII-/- bone marrow. Average percentages of 
CD4+ SP T cells are shown (± SEM). The bar diagram in the upper right panel shows 
the percentages of CD4+ T cells versus CD8+ T cells in the four different bone 
marrow chimeras (P values are indicated). (B) Self-reactive potential of CD4+ SP T 
cells that developed in the absence of antigen presentation by DC or mTEC or both. 
H3 thymidin incorporation of CD4+ SP T cells isolated from the four different 
combinations of bone marrow chimeras 6 weeks after reconstitution (see A) and 
cultivated with WT lymph node DC for 4 days is shown. (C) Unaltered percentage of 
Treg. The graph depicts percentages of CD4+ Foxp3+ T cells in WT or C2TAkd 
recipients reconstituted with either WT or MHCII-/- bone marrow (P = n.s.). 
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3.8 Impaired negative selection of Ovalbumin-specific T cells 
 
Next we aimed to directly address the role of antigen presentation by mTEC in 
negative selection versus Treg development by taking advantage of a TCR transgenic 
approach which would enable us to study tolerance induction of T cells with known 
specificity. We used a previously described model system in which mTEC-specific 
expression of Ovalbumin (Ova) in AIRE-HCO mice led to massive deletion of Ova-
specific T cells (DO11.10) (62, 194). In the absence of Ova, DO11.10 transgenic T 
cells were normally selected and represented the majority of naïve CD4+ SP T cells 
in WT as well as in C2TAkd thymi (69.4 ± 6.7 (n = 10) versus 73.5 ± 5.4 (n = 10); P = 
0.14) (Figure 13A). In the presence of cognate antigen in AIRE-HCO x DO11.10 
nimals a large proportion of DO11.10+ T cells was lost. Importantly, the deletion of 
DO11.10+ T cells was nearly reversed when mTEC were impaired to present the 
cognate antigen in C2TAkd x AIRE-HCO x DO11.10 mice (24.1 ± 6.2 (n = 12) versus 
53.2 ± 10 (n = 14); P = 4 × 10-9) (Figure 13A and 13B).  
To exclude the possibility that altered HCO expression in C2TAkd mice might have 
led to the impaired deletion of DO11.10+ T cells, expression analysis of HCO in WT 
versus C2TAkd mice was performed. Results clearly showed comparable HCO levels 
in C2TAkd x AIRE-HCO and AIRE-HCO thymi (Figure 13C). 
 
 
a
A 
47 
 
48 
 
B C 
 
 
Figure 13 – Reduced negative selection of DO11.10+ T cells in DO11.10 × AIRE-
HCO × C2TAkd mice. (A) Altered deletion in DO11.10 × AIRE-HCO × C2TAkd mice. 
The plots depict CD4 and CD8 stainings of thymocytes of 6-weeks-old DO11.10 and 
C2TAkd mice (upper left) or DO11.10 x AIRE-HCO and DO11.10 x AIRE-
CO x C2TAkd (upper right) mice. In the respective histograms below CD4+ SP T 
cells stained for DO11.10 are shown. Numbers indicate the average frequency (± 
s.d.) of cells within these areas. (B) The diagram depicts the percentage of DO11.10+ 
cells of CD4+ SP T cells of DO11.10, DO11.10 × AIRE-HCO and DO11.10 × AIRE-
HCO × C2TAkd mice (P values are shown). (C) Quantification of HCO-expression. 
Quantification of relative HCO expression in CD80hi and CD80lo mTEC as well as DC 
isolated from AIRE-HCO or AIRE-HCO x C2TAkd animals is depicted in the graph. 
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3.9 Enhanced induction of DO11.10+ T C2TAkd mice 
 
While DO11.10 single-transgenic T cells developed into naïve CD4+ SP T cells, the 
same cells were strongly deleted in the presence of cognate antigen. The remaining 
cells were found to contain a substantial fraction of Ova-specific Treg, identified by the 
expression of Foxp3. Therefore we sought to ascertain the consequence of 
diminished antigen presentation by mTEC on Treg development. Interestingly, 
C2TAkd × DO11.10 × AIRE-HCO animals, beside diminished deletion of Ova-specific 
T cells, were found to exhibit a significant increase in the % of Foxp3+ DO11.10+ 
CD4+ SP T cells (5.2 ± 2.1, n = 11 versus 14.3 ± 2.4, n = 13; P =  1.5 x 10-9) (Figure 
14A). This was also reflected in the absolute cell numbers of Ova-specific Treg (Figure 
14B).  
Together we showed that the reduced presentation of HCO by down-modulation of 
HCII on mTEC diminished deletion and at the same time favored Treg induction of 
.   Our observations would be in accordance of an avidity model 
of tolerance induction, whereby the threshold for negative selection lies above the 
reg in 
M
HCO-specific T cells
optimal avidity window for Treg induction.  
A 
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Figure 14 – Increased selection of Treg in DO11.10 x AIRE-HCO x C2TAkd mice. 
) Increased percentage of Ova-specific Treg in DO11.10 x AIRE-HCO x C2TAkd 
lude the possibility that the above described findings were just a particular 
 cells in WT as well as in C2TAkd animals 
(Figure 15A) (29.7 ± 4.2 (n = 7) versus 32.5 ± 2.8 (n = 8), P = 0.17), HA-specific T 
cells were deleted in AIRE-HA mice that expressed HA exclusively in mTEC (Figure 
15A). Importantly, interfering with antigen presentation by mTEC, C2TAkd × TCR-HA 
× AIRE-HA animals exhibited reduced deletion of HA-specific T cells (5.9 ± 2.2 (n = 
6) versus 14.5 ± 4.9 (n = 14), P = 5 x 10-5) which is in line with the results obtained by 
the DO11.10 model (Figure 15A and B). 
Reminiscent of the DO11.10 system, Treg development was also affected, being 
strongly increased in C2TAkd × AIRE-HA × TCR-HA mice with respect to 
percentages (2.9 ± 0.5 (n = 6) versus 7.9 ± 3.4 (n = 14), P = 9 x 10-5) as well as 
absolute cell numbers of HA-specific Treg (Figure 15C and D).  
Similar results were obtained using a system in which HA was ubiquitously 
expressed (Pgk-HA) (Figure 16A-C) (216).  
 
(A
mice. Depicted are CD4+ SP T cells of DO11.10, DO11.10 x AIRE-HCO or DO11.10 
x AIRE-HCO x C2TAkd mice stained for Foxp3 and DO11.10. The average 
percentages of Foxp3+ DO11.10+ T cells are shown (± SEM). (B) The diagrams 
depict the absolute numbers of Foxp3+ DO11.10+ and Foxp3- DO11.10+ T cells of 
DO11.10, DO11.10 x AIRE-HCO or DO11.10 x AIRE-HCO x C2TAkd mice (P values 
are indicated). 
 
 
3.10 Impaired deletion and enhanced Treg induction of HA-specific T cells 
 
To exc
attribute of the DO11.10 TCR, a second TCR transgenic mouse model was tested. 
As previously described by our lab, Hemagglutinin (HA) expression by mTEC led to 
partial deletion and concomitant Treg induction of TCR-HA transgenic T cells (62). 
While TCR-HA single transgenic T cells normally developed into naïve T cells and 
composed roughly 30% of all CD4+ SP T
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Figure 15 – Altered selection of HA-specific T cells in TCR-HA × AIRE-HA × 
C2TAkd mice. (A) Diminished deletion in TCR-HA × AIRE-HA × C2TAkd mice. 
Histograms depict staining of CD4+ SP T cells for TCR-HA from either 6-weeks-old 
TCR-HA and TCR-HA × C2TAkd mice (lower left panel) or TCR-HA × AIRE-HA and 
TCR-HA × AIRE-HA × C2TAkd mice (lower right panel). The respective CD4 and 
CD8 profiles are shown above (upper row). Numbers indicate the average frequency 
(± s.d.) of cells within these areas. (B) The graph displays the percentages of TCR-
HA+ cells of CD4+ SP T cells of individual TCR-HA, TCR-HA × AIRE-HA and TCR-HA 
× AIRE-HA × C2TAkd animals. P values are indicated. (C) Enhanced Treg induction in 
TCR-HA × AIRE-HA × C2TAkd mice. The plots depict TCR-HA versus Foxp3 
stainings of CD4+ SP T cells from TCR-HA (left) and TCR-HA × AIRE-HA or TCR-HA 
× AIRE-HA × C2TAkd thymi. Numbers indicate the average frequency (± s.d.) of cells 
within these areas. (D) Absolute cell numbers of HA-specific Treg (left) and naïve T 
cells (right) from TCR-HA, TCR-HA × AIRE and TCR-HA × AIRE-HA × C2TAkd 
e shown in the graph, P lues are indicated.  animals ar  va
52 
 
 
Figure 16 - Altered selection of HA-specific T cells in TCR-HA × Pgk-HA × 
C2TAkd mice. (A) Diminished deletion in TCR-HA × Pgk-HA × C2TAkd mice. The 
plots depict stainings of thymocytes of 6-week-old TCR-HA × Pgk-HA or TCR-HA × 
Pgk-HA × C2TAkd mice for CD4 and CD8 (upper row). The respective histograms 
below show stainings of CD4+ SP T cells from TCR-HA × Pgk-HA and TCR-HA × 
Pgk-HA × C2TAkd mice for TCR-HA (lower row). Numbers indicate the average 
frequency (± s.d.) of cells within these areas. (B) The percentages of TCR-HA+ cells 
of CD4+ SP T cells of individual TCR-HA, TCR-HA × Pgk-HA and TCR-HA × Pgk-HA 
× C2TAkd animals are shown in the graph. P values are indicated. (C) Increased Treg 
induction in TCR-HA × Pgk-HA × C2TAkd mice. CD4+ SP T cells form TCR-HA and 
TCR-HA × Pgk-HA or TCR-HA × Pgk-HA × C2TAkd mice were stained for TCR-HA 
and Foxp3. Numbers indicate the average frequency of cells within these areas (± 
s.d.).  
A 
B C 
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3.11 Dendritic cells are dispensable for the deletion and Treg induction of Ova-              
specific T cells 
 
Our observations clearly suggest an autonomous role of mTEC in CD4 T cell 
tolerance not only as antigen producer but also as antigen presenter. However, 
considering the recent finding that intact peptide-MHC complexes can be efficiently 
transferred to and presented by DC, an alternative explanation needed to be 
considered (207, 211). Accordingly, the altered selection of CD4+ T cells might as 
well be a secondary effect of the C2TA knock-down and might be a consequence of 
diminished pMHC complex transfer to DC.  
Thus we aimed to address this issue and ascertain the role of DC in the two TCR-
ed, by removing DC from the system. To this end, we took 
antage of mice that expressed diphtheria toxin A (DTA) under the control of a 
loxP-flanked neomycin resistance (neoR) cassette from the ROSA26 locus and 
crossed them to CD11c-Cre mice leading to the physical ablation of DC (ΔDC) (201). 
To ascertain the contribution of DC to tolerance induction in DO11.10 × AIRE-HCO 
mice, AIRE-HCO or AIRE-HCO × C2TAkd animals were reconstituted with DO11.10 
or DO11.10 × ΔDC bone marrow. While DO11.10+ T cells were normally selected in 
WT animals reconstituted with DO11.10+ bone marrow, DO11.10+ T cells were 
deleted in recipients expressing Ova in mTEC (83.0 ± 4.1 (n = 3) versus 37.7 ± 8.5 (n 
= 8), P = 3 x 10-6)   (Figure 17A). Importantly, deletion was not affected in AIRE-HCO 
mice that were devoid of DC (37.7 ± 8.5 (n = 8) versus 24.67 ± 15.4 (n = 8), P = 0.6) 
plying a redundant role of DC in the deletion of Ova-specific T cells (Figure 17A). 
system in the absence of DC (Figure 18). 
transgenic models us
adv
im
In contrast to this, C2TAkd × AIRE-HCO mice reconstituted with ΔDC bone marrow 
and therefore free of DC, showed strongly reduced deletion of DO11.10+ T cells 
(Figure 17A) (24.67 ± 15.4 (n = 8) versus 70.5 ± 10.5 (n = 10), P = 1 x 10-5), which 
can only be a consequence of diminished Ova presentation by mTEC. In accordance 
with this, induction of Ova-specific Treg was also unaffected by the absence of DC in 
AIRE-HCO mice reconstituted with DO11.10 ΔDC bone marrow, whereas interfering 
with antigen presentation by mTEC significantly enhanced Treg induction even in the 
absence of DC (2.8 ± 4.9 (n = 8) versus 10.0 ± 4.0 (n = 8), P = 0.005)   (Figure 17B). 
The same held true for the absolute cell numbers of DO11.10+ Foxp3+ CD4+ SP T 
cells (Figure 17C). Essentially the same findings were obtained in the TCR-HA 
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Figure 17 – Altered selection of DO11.10+ T cells in DO11.10 x AIRE-HCO x 
C2TAkd mice is independent of DC. (A) Analysis of DC-deficient (ΔDC) bone 
marrow chimeras. WT recipients and AIRE-HCO or AIRE-HCO x C2TAkd recipients 
were either reconstituted with DO11.10 or DO11.10 x ΔDC bone marrow and 
CD4/CD8 T cell profiles as well as the percentage of CD4+ DO11.10+ cells of 
chimeric animals were analyzed 6 weeks later. Numbers indicate the average 
stainings of CD4+ SP T cells from AIRE-HCO and AIRE-HCO x C2TAkd recipients 
reconstituted with DO11.10 x ΔDC bone marrow. Numbers indicate the average 
frequency of cells within these areas (± s.d.). (C) Absolute cell numbers of DO11.10+ 
Foxp3+ cells are shown in the graph. P values are indicated.  
frequency of cells within these areas (± s.d.). (B) Plots depict DO11.10 and Foxp3 
B 
A 
C 
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Figure 18 – Altered selection of TCR-HA+ T cells in TCR-HA x AIRE-HA x 
C2TAkd mice is independent of DC. (A) Analysis of ΔDC bone marrow chimera. 
-HA x C2TAkd recipients were either 
nstituted with TCR-HA or TCR-HA x ΔDC bone marrow and CD4/CD8 T cell 
A 
B 
WT recipients and AIRE-HA or AIRE
reco
profiles as well as the percentage of CD4+ TCR-HA+ T cells of chimeric animals were 
analyzed 6 weeks later. (B) Plots depict TCR-HA and Foxp3 stainings of CD4+ SP T 
cells from AIRE-HA and AIRE-HA x C2TAkd recipients reconstituted with TCR-HA x 
ΔDC bone marrow. Numbers indicate the average frequency of cells within these 
areas (± s.d.).  
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4. DISCUSSION 
 
Ever since the discovery of medullary thymic epithelial cells (mTEC) and their 
in ensable role in central tolerance induction, the mechanism(s) of how mTEC 
might contribute to this important task has been the center of investigations. The 
unique hallmark of mTEC is their capacity to express rare, otherwise tissue restricted 
genes thereby crucially contributing to the prevention of autoimmunity against 
peripheral organs. Hence, mTEC have a major function as antigen expressing cell, 
however, whether they also induce tolerance by direct antigen presentation to T cells 
is not known. We addressed this issue by generating a tissue-specific C2TAkd 
mouse and directly interfering with antigen presentation by mTEC in vivo. 
Here, we show that mTEC serve a dual, non-redundant function in tolerance 
induction of CD4+ T cells not only as antigen expressing cell but also as antigen 
presenting cell.  
 
4.1 Transcriptional and translational RNA interference in C2TAkd mice? 
 
Analysis of C2TAkd mice revealed efficient down regulation of MHCII mRNA and 
protein expression in mTEC. Quantification of C2TA mRNA, which is the actual target 
of the miRNA, showed a milder reduction as compared to MHCII. A plausible 
explanation for this finding could be the type of RNA interference (RNAi) that is 
induced. Generally miRNAs can regulate gene expression on two levels; first, by 
assembly into the RNA induced silencing complex (RISC) and the subsequent 
binding to and endonucleolytic cleavage of the target mRNA or second, by binding to 
the 3´UTR region of the target mRNA and inhibition of its translation. In other words, 
iRNAs can either repress the amount of mRNA and protein or only the amount of 
rotein. Why and when a particular mode of RNAi is induced by a specific miRNA is 
disp
m
p
still poorly understood. However, there are multiple examples showing either no 
change in mRNA level or a significant smaller reduction of the mRNA level as 
compared to the protein level, indicating that both transcriptional and translational 
silencing can be concomitantly induced by a single miRNA (217-220).  Thus, it is 
likely that in C2TAkd mice mRNA and protein levels of C2TA are repressed at the 
same time, thereby synergistically leading to the strong reduction of MHCII. 
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Another possible explanation would be that the transcription of MHCII is very 
sensitive to alterations in the abundance of the co-activator C2TA. This would mean 
at already a moderate knock down of C2TA would be sufficient for a strong 
 however, is rather unlikely as 
C2TA+/- mice do not show significant alterations in MHCII expression as compared to 
WT mice (data not shown). 
 
4.2 Specificity of C2TA for MHCII 
 
The choice of C2TA as the miRNA target instead of MHCII itself was based on the 
fact that this would enable us to study antigen presentation by mTEC irrespective of 
the genetic background, e.g.  Balb/c and BL6. Furthermore, C2TA is considered to 
be the master regulator of MHCII transcription. Accordingly C2TA-/- animals by and 
large recapitulate the phenotype of MHCI-/- mice and thus are devoid of MHCII 
expression (215). Indeed we found that less than 1% of all mTEC expressed MHCII 
at very low levels on their surface (data not shown + (43)).  
Even though C2TA has a remarkable degree of specificity for MHCII and genes 
involved in the MHCII loading pathway (221-228), a few MHCII-unrelated genes have 
been reported to be influenced by C2TA. In all cases, however, expression was only 
very mildly regulated by C2TA and not observed in vivo or were subject of 
controversy (229, 230). Beside transcriptional repression of IL-4, FasL and Collagen 
α2 (225, 231-233), C2TA was also reported to up-regulate expression of MHCI and 
the co-stimulatory molecule Plexin A1 (213, 214, 234). Importantly, we tested all 
known targets of C2TA and found them either not to be expressed in mTEC or not 
differentially regulated in C2TAkd mTEC (Figure 7 + data not shown). Thus, potential 
unwanted effects of C2TAkd on other C2TA-regulated genes than MHCII can be 
largely excluded. 
 
4.3 Potential off-target effects 
 
Endogenous, naturally occurring miRNA and their mode of action have been 
thoroughly investigated in the last decade. Today it is known that a given miRNA 
usually targets much more than one mRNA as its function does not require full 
th
reduction of MHCII mRNA transcription. This scenario,
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complementarity to the target (235) but instead a so called “seed region” of about 8 
bases at  the 5´end is essential and sufficient for effective repression of target mRNA 
anslation. Bioinformatic predictions in mammals estimated that a few hundred 
 respect to 
s well as the generation of a second C2TAkd mouse, carrying a 
ifferent hairpin, will uncover such off-target effects. 
.4 mTEC development in C2TAkd mice 
tr
miRNAs control approximately 30% of all protein-encoding genes (236).  
Although the algorithm of the miRNA design program we used for the C2TA-specific 
miRNA design (http://katahdin.cshl.org:9331/RNAi_web/scripts/main2.pl) excluded 
sequence homologies to other genes than C2TA, it cannot be entirely excluded that 
the C2TA-specific miRNA represses the translation of other transcripts. This 
technical caveat is also known as “off-targeting”. 
Therefore we carefully analyzed the phenotype of C2TAkd mTEC, including all 
known markers, e.g. MHCII, CD80, AIRE, MHCI, UEA-1, pGE (Figure 8,9 and data 
not shown). Except for the down-modulation of MHCII, no alterations with
the markers we tested could be detected. Formally, however, this possibility still has 
to be considered. Future microarray analysis of mTEC from WT versus C2TAkd 
versus C2TA-/- a
d
 
4
 
It is well established that efficient TEC development depends on the cross-talk with 
developing T cells (237-239), involving CD40-CD40L as well as RANK-RANKL 
interactions (37-39). One study, however, also proposed a requirement of cognate 
pMHC-TCR interactions for the development of mature AIRE+ mTEC (43). This 
hypothesis was based on the observation that mice expressing only one TCR and 
thus supposedly did not interact with peptide-MHCII (pMHCII) complexes on mTEC 
showed strongly reduced numbers of mTEC. Importantly, the mTEC compartment 
was completely restored when the cognate antigen of the TCR was expressed. The 
authors attributed this defect to the reduced proliferation they observed in the 
residual mTEC and suggested a model by which proliferating precursors in the 
immature mTEC population differentiate and/or expand into mature mTEC via the 
help of cognate self-peptide MHCII complex interactions with self-reactive CD4+ T 
cells.  
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In consideration of these findings, we performed detailed analysis of mTEC 
development. Beside the normal appearance of the thymic architecture, all major 
mTEC subsets were normally formed. AIRE+ mTEC that were notably most affected 
in the above mentioned study, were not reduced in C2TAkd animals as compared to 
WT. If anything at all, a slight increase of AIRE protein could be observed in C2TAkd 
mTEC. Our findings, however, do not necessarily contradict the hypothesis described 
bove. First, even though MHCII is strongly reduced in C2TAkd mice, there is still 
al MHCII, which might be sufficient and essential 
r the development of a full mTEC compartment because it still allows for cognate 
so be explained by secondary effects, such as disrupted medulla 
rmation and consequently hampered DC recruitment or T cell intrinsic defects (36). 
bserved an altered thymic architecture nor mTEC 
evelopment, but exclusively diminished MHCII expression by mTEC, leaving the 
a
some low expression level of residu
fo
pMHC-TCR interactions. The lack of MHCII could be compensated for by increased 
proliferation of mTEC subsets, a possibility that we did not test for. Second, as C2TA 
miRNA expression is under the control of the AIRE promoter, MHCII is most strongly 
down-regulated in mature mTEC while immature CD80- mTEC are affected to a 
lesser extent. Hence, TCR – pMHC interactions between immature mTEC and T cells 
could still take place in C2TAkd animals which might be sufficient for proper mTEC 
development. 
 
4.5 Negative selection in C2TAkd mice  
 
The highly efficient and mTEC-specific C2TA knock down in C2TAkd mice, resulting 
in a strong reduction of MHCII, allowed us to directly investigate the consequences of 
impaired antigen presentation by mTEC on tolerance induction in CD4+ T cell.  
Analysis of bulk CD4+ T cell development in C2TAkd mice revealed an increase of 
CD4+ SP T cells of about 30%. This observation is in agreement with another report 
that found a similar enlargement of the CD4+ SP T cell compartment in mice that 
were completely devoid of UEA+ mTEC. In this study, however, impaired tolerance 
induction could al
fo
In contrast to this, we neither o
d
thymic environment fully intact. Thus, alterations in T cell development can only be a 
direct result of diminished MHCII levels in mTEC. 
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An increase in the CD4+ SP T cell compartment was also found when the role of DC 
in negative selection was studied. Chimeric mice reconstituted with MHCII-/- bone 
marrow to abolish antigen presentation by DC showed an enrichment of CD4+ SP T 
cells which was supposedly caused by defective deletion of self-reactive T cells 
 and mTEC were diminished in 
ntigen presentation is clearly in agreement with a non-redundant function of mTEC 
+ lls.  
ht compensate for the absence of one or the other APC type, changes on the 
level of TCR specificities could still occur. Alterations in the TCR repertoire of Treg can 
(202). This interpretation has later been strengthened by the fact that T cells from 
such chimeras indeed showed elevated auto-reactivity in vitro (240). Essentially the 
same conclusions were drawn from the analysis of DC knockout animals that were 
found to develop severe autoimmune disease, presumably as a consequence of 
defective negative selection (201).  
Here we further clarified the role of mTEC versus DC in negative selection, using 
different bone marrow chimeras that were designed to eliminate antigen presentation 
by either mTEC or DC and found that in both cases negative selection of CD4+ T 
cells was impaired. This became apparent by the enlargement of the CD4+ SP 
compartment and the ability of these cells to react towards self-peptide-MHC 
molecules in an in vitro proliferation assay. The observation that the increase of CD4+ 
SP T cells was even more pronounced if both DC
a
and DC as APC in the deletion of CD4  T ce
 
4.6 Treg induction in C2TAkd mice 
 
mTEC have been implicated in the induction of regulatory T cells (Treg). As previously 
established in our lab, expression and presentation of HA by mTEC was sufficient for 
the development of HA-specific Treg and moreover, mTEC as well as DC were found 
to autonomously induce Treg in vitro (62, 241). In contrast, here we did not observe 
any significant changes in the polyclonal CD4+ Treg compartment in mice diminished 
in antigen presentation by mTEC or DC, at least not with respect to the pool size. Of 
note, we always found a marked, yet not significant reduction of Treg in mice devoid of 
antigen presentation by both mTEC and DC. Our findings do not necessarily imply a 
complete redundancy of mTEC and DC in the process of Treg induction. While 
homeostatic mechanisms acting downstream of bona fide differentiation processes of 
Treg mig
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certainly not be detected in a polyclonal system. This might as well explain why 
neither the complete absence of mTEC by blocking their development nor the lack of 
DC promoted significant perturbation in the size of the Treg compartment (37, 201).  
A major limitation inherent to analysis of the polyclonal T cell repertoire is that 
defective tolerance induction on the level of distinct TCR specificities is difficult to 
address.  Therefore we ascertained the role of antigen presentation by mTEC in 
negative selection as well as in Treg induction by using a TCR transgenic mouse 
model. As we previously published, targeted expression of Ova as well as HA to 
AIRE+ mTEC led to the development of CD4+ Foxp3+ Treg of the cognate TCR 
specificity concomitant to the partial deletion of specific TCR-transgenic CD4+ T cells. 
Interfering with antigen presentation by mTEC in these systems resulted in 
diminished deletion and remarkably, increased Treg development of TCR-transgenic 
CD4+ T cells. This indicates that mTEC promote the selection of certain Treg 
specificities, supposedly recognizing mTEC-derived antigens such as TRA, thereby 
crucially contributing to the repertoire formation of CD4+ Treg. Moreover, our 
observations provide direct evidence for an autonomous role of mTEC as APC not 
nly in recessive tolerance but also the dominant tolerance induction of CD4+ T cells. 
.7 Antigen transfer to DC 
it has 
might have led to reduced capture 
of MHCII molecules by DC and thus to the altered tolerance induction we observed in 
o
 
4
 
Antigen transfer between different types of APC has been suggested to substantially 
contribute to increase the efficiency of tolerance induction (242). For example 
been shown that Ova transfer to DC was not only sufficient but also essential to 
induce negative selection of Ova-specific TCR transgenic CD4+ T cells (203). 
Recently much progress has been made to understand the modalities of antigen 
spreading within the thymic microenvironment. There appears to be a unidirectional 
transfer of mTEC-derived antigens, including rare tissue specific antigens, from 
mTEC to DC. Efficient antigen capture and presentation by DC does not only engage 
conventional MHCII loading pathways but also extends to the level of intercellular 
transfer of functional MHC molecules and other TEC-specific membrane proteins 
(207, 211). In view of this new observations, we addressed the possibility that 
reduced MHCII levels on mTEC in C2TAkd mice 
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CD4+ T cells. To this end we eliminated DC in the TCR-transgenic systems we 
previously used to test the importance of mTEC as antigen presenters and found that 
neither deletion nor Treg induction of HA- or Ova-specific T cells was dependent on 
DC.  
 
4.8 Avidity impinge on the mode of tolerance 
 
Analysis of the TCR transgenic models showed that antigen presentation of HA or 
Ova by mTEC always led to both deletion and concomitant Treg induction of CD4+ T 
tion is favored upon low avidity 
teractions which might lead to shaping the repertoire towards low abundance 
owever, it is still unresolved why within an apparently homogenous cohort of T 
cells specific for the antigen, implying that these two different tolerogenic pathways 
can occur side by side. Large amounts of antigen presented by mTEC induced 
massive deletion of specific T cells, whereas reducing the amount of antigen on 
mTEC favored Treg development and inhibited negative selection of T cells 
recognizing the cognate antigen. Thus, our findings, for the first time, provided 
evidence for a model by which Treg induction occurs within a defined “window of 
avidity” which is below the threshold of negative selection, whereby  the optimal 
antigen dose might vary between different TCR affinities as well as different APC, i.e. 
DC and mTEC (241). This would imply that Treg induc
in
antigens such as TRA. 
H
cells, all expressing the same TCR, one T cell develops into a Treg while another T 
cell is deleted in one and the same antigen expressing environment. We provide 
several potential explanations: First, there is more and more evidence that the thymic 
medulla is rather heterogeneous with respect to availability of antigens, in particular 
with respect to low abundant antigens. Accordingly, it has been shown for 
promiscuously expressed genes that a given TRA was expressed by only about 3-
5% of all mTEC (209). Therefore it might be a stochastic event whether a T cell runs 
into an APC presenting its cognate antigen. Second, T cells were shown to have a 
residence time of about 4 days in the medulla during which they have multiple 
interactions with APC thereby probably screening their environment for antigens 
(210). In view of this, one could speculate that a single pMHC-TCR contact might not 
be sufficient to induce tolerance but instead multiple consecutive interactions are 
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required for Treg induction or deletion. Third, the medulla is a patchwork of different 
types of APC, all of which might have different tolerogenic properties. For example it 
has been recently shown that mTEC require higher optimal antigen doses for Treg 
 
induction compared to DC (194). Forth, the susceptibility for tolerance induction 
might also be intrinsically regulated with the maturation stage. Accordingly, it was 
found that the capacity to deviate into the Treg lineage inversely correlated with the 
maturation status (194). Similar rules could also apply for negative selection. 
Together, several stochastic and probabilistic factors might impinge on the mode of 
tolerance that is induced. Depending on the encounter of different APC, the 
maturation status of the T cell and the availability of the cognate antigen, a T cell 
might be deleted or deviated into the Treg lineage. It is intuitive that the amount of 
antigen on APC dictates the probability of interactions with T cells expressing the 
cognate TCR and thereby influences the mode of tolerance that is induced. 
Therefore there might be a balance between Treg induction and negative selection, 
which is shifted to the one or the other direction depending on the availability of the 
given antigen (Figure 19).     
 
 
Figure 19 - Avidity model of central tolerance induction. The avidity of TCR - self 
peptide MHC interactions influences the mode of tolerance that is induced. 
Accordingly, high antigen doses lead to a strong susceptibility for negative selection, 
whereas lower antigen doses increase to probability of a T cell to be deviated into the 
Treg lineage. Thus there is an optimal window of avidity for the development of Treg 
that might partially overlap with positive selection or deletion. This could explain why 
deletion and Treg induction of T cells with the very same TCR can often occur in 
parallel in vivo.   
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5. MATERIAL AND METHODS 
 
Animals 
TCR-HA, DO11.10, PGK-HA, C2TA-/- has been described elsewhere (215, 216, 243, 
44). AIRE-GFP reporter mice were kindly provided by Dr. Mark Anderson (63). 
d from Dr. David Vöhringer (201). 
57-BL6 and Balb/c mice were purchased from Charles River. All other strains were 
), CD80 (B7.1, 16-10A1) were purchased from Becton 
2
CD11c-Cre and DTA-floxed mice were obtaine
C
from in-house breeding colonies. AIRE-HCO, AIRE-HA, C2TAkd mice were 
generated at the Research Institute of Molecular Pathology (62).  All mice were breed 
in individually ventilated cages in the animal facility of the Research Institute of 
Molecular Pathology or in the animal facility of the Institute for Immunology of the 
LMU Munich.  All animal studies were done according to the local regulations. 
 
Antibodies and flow cytometry  
Phycoerythrin (PE)-conjugated  mAbs to CD45.1 (A20), Ly51 (BP-1), Cy-chrome-
conjugated  mAbs to CD8 (53-6.7), CD45 (Ly-5), CD11c (HL3), allophycocyanin 
(APC)-conjugated mAbs to CD45.1 (A20), phycoerythrin-Cy7 (PE-Cy7)-conjugated 
streptavidine, mAbs to CD25 (PC61), allophycocyanin-Cy7 (APC-Cy7)-conjugated 
mAbs to CD4 (GK1.5) and biotin-conjugated monoclonal antibodies (mAbs) to CD8 
(53-6.7), CD4 (GK 1.5
Dickinson. APC-conjugated EpCAM (G8.8) was purchased from BioLegend.  
Monoclonal Abs to EpCAM (G8.8), TCR-HA (6.5), DO11.10 (KJ1.26) and pan-MHC 
class II (P7.7) were purified from hybridoma supernatant and conjugated to FITC, PE 
or Alexa647 in our lab. 4',6-Diamidin-2'-phenylindol- dihydrochlorid (DAPI) was 
purchased from Invitrogen. 
Intracellular staining of Foxp3 was performed according to the manufacturer’s 
protocol using FITC–, PE- or APC-conjugated mAbs to Foxp3 (FJK-16s, 
eBiosciences). Surface stainings were performed according to standard procedures 
at a density of 1-2 x 106 per 50 μl and volumes were scaled up accordingly. Flow-
cytometric analysis was performed on FACS Canto II (Becton Dickinson) using FACS 
DIVA software (Becton Dickinson) for acquisition and Flowjo (Treestar) for analysis. 
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Immunofluorescence  
5μm frozen sections were fixed in cold acetone and permeabilized with 0.1% (vol/vol) 
Tween in PBS for 30 min. Sections were blocked with 10% (vol/vol) FCS in PBS for 
30 min and washed 3 x 15min in 0.1% (vol/vol) Tween in PBS. Rabbit anti-keratin 5 
antibody (Covance, 1:100) staining was carried out overnight at 4°C. Next day 
sections were washed 3 x 15min and incubated with Alexa Fluor 488-conjugated 
secondary anti-rabbit antibody (Molecular Probes, 1:800) for 60 min at room 
th ProLong Gold antifade reagent with 4, 6-diamidino-2-
henylindole (DAPI) (Molecular Probes) and samples were analyzed with the 
fluorescence microscope BX41 (Olympus).   
 
Western blotting 
1x106 (5x105) cells were lysed in 50µl (20µl) lysis buffer at 4°C for 5 min. 1x sample 
buffer was added and lysate was boiled at 95°C for 4 min. Subsequently samples 
were loaded on a SDS-PAGE (see below). 
SDS-PAGE 
Running gel (15%) Loading gel 
temperature. After washing 3 x 15 min, sections were blocked with rabbit serum 
(Jackson Immuno Research Laboratories, Inc.) for 30 min at room temperature and 
incubated with biotin anti-keratin 8 antibody (TROMA-1, Developmental Studies 
Hybridoma Bank, 1:100), biotin anti-AIRE antibody (5H12-2, kindly provided by Dr 
Hamish Scott, 1:400) or biotin anti-I-Ad (AMS-32.1, Becton Dickinson, 1:800) for 2 h 
at room temperature. Subsequently sections are washed 3 x 15min and the 
secondary reagent straptavidin-Cy3 (Jackson Immuno Research Laboratories,Inc., 
1:1000) was added for 60 min at room temperature. Finally after washing 3 x 15min 
nuclei were counterstained wi
p
 
H2O 4.9ml 6ml 
1.5M TrisHCl+0.4% SDS (pH6.8) 5ml 2.5ml 
29.2% acrylamid+0.8% bis-acrylamid 10ml 1.5ml 
10% TEMED 100µl 100µl 
10% ammonium-persulfat (APS) 100µl 100µl 
< 10ml per 1.5mm gel 
< 4ml per 1.5mm gel 
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Sample Buffer (3x) 
H2O     ad40ml 
HCl pH6.8  12 ml 
 PBS 
Running Buffer (10x) 
Electrophoresis unit: LKB2117 Multiphor II, LKB 
0.5M Tris-
Glycerol    8 ml 
20% SDS    10 ml  
(0.05%) Bromphenolblue    
ß-Mercaptoethanol    20 µl/ml  
Lysepuffer 
Triton X    1%     
Aprotinin/ml     100KIU    
Pefablock      0.16mM    
Na Azid      0.1% 
in
Tris base    30.3 g 
Glyzin     144.0 g 
SDS     10g 
H2O      1l 
 
Blotting 
A semidry blotting chamber (LKB 2117 Multiphor II electrophoresis unit) was used to 
transfer the proteins to the membrane. The blotting procedure was carried out as 
depicted in the scheme below (scheme). The chamber was connected to 160mA for 
2h. 
 
Semi-dry blotting: 
filter paper: GB003 (3mm), Schleicher & Schuell 
(soaked in buffer) 
membrane: PVDF, 0.45µm, Roche 
(soaked in Methanol and washed with H2O) 
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After transfer of proteins the membrane was transferred to a blocking solution (4% 
 agarosegel and purified using the Gel 
it (Quiagen).   Before ligation vector backbones were dephosphorylated 
ith 10U alkaline phosphatase (Roche t 7°C for 1h. 
on was performed using quick lig ioLabs) with th propriate buffer for 
of insert and backbone were used. 10µl 
ligation mix was incubated together with competent E.coli (DH5α), provided by the 
m h, followed by a heat shock of 2min at 
transfected bacteria wer ked on LB-Ag s containing the 
 mark
milk powder) for 1h on room temperature. Thereafter the primary antibody was added 
and incubated over night at 4°C. Next day the membrane was thoroughly washed (8 
x 5min) with wash buffer (PBS supplemented with 0.05% Tween20) before it was 
incubated with the secondary antibody (in 4% milk powder) for 4h on room 
temperature. After thoroughly washing at least 8 x 5min substrate is added for 5 min 
and the membrane can be exposed to the film. 
Antibodies for WB 
Mouse anti mouse β-actin (AC-15, Sigma-Aldrich; 1:20000) 
Polyclonal rabbit anti mouse horse radish peroxidase (HRP) (P260, DAKO; 1:2000) 
Rat anti mouse MHCII (H2-Ea) (IBL-5/22, Santa Cruz; 1:200) 
Polyclonal mouse anti rat HRP (212-035-168, Dianova; 1:9000) 
Polyclonal rabbit anti AIRE (Hamish Scott; 1:100) 
Polyclonal goat anti rabbit HRP (111-035-144, Dianova; 1:70 000) 
Substrate: Super Signal West Pico (Pierce) 
Film: WICORex B+ (Linhardt Röntgenbedarf) 
Developer: 35 Compact (PROTEC) 
 
 
Cloning 
Restriction enzymes were purchased from Roche. Digestions of plasmids were 
performed in the appropriate buffers with 10U restriction enzyme at 37°C or 55°C for 
1h. Cut vectors were separated on a 1-2%
purification K
w ) with the appropria e buffer at 3
Ligati ase (B e ap
5min on 25°C. Equal stoechiometric amounts 
IMP service department, on ice for 20 in wit
42°C. Finally e strea ar plate
appropriate antibiotic as selection er. 
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Cloning of the retroviral CIITAsh vector (LMP CIITAsh)  
LMP vector was purchased from 
prov ed th ng regions of the human miRNA30 (scheme) 
 gene of interest, the miRNA30 can be 
 i o the sequence s for this gene. Subsequently this “designer 
iRNA processing pathway and this 
e aimed to target MHCII by either 
specific sequences. 
://katahdin.cshl.org:9331/homepage/siRNA/RNAi.cgi?type=shRNA
The murine stem cell virus (MSCV)-based 
OpenBioscience and id e flanki
(245). In order to obtain the knock-down of a
exchanged nt  pecific 
miRNA” will be normally processed in the m
ultimately leads to efficient knock-down. Here w
using C2TA-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CIITA (MH3-6) specific short hairpins (97mers) were designed with the help of the 
website: 
 http   
The RNAi oligo retriever generated the hairpin primer by selecting a ‘sense’ 
sequence of 22 nucleotides (nt) in ding sequence of the gene of 
interest. Generally there are seve
applied to the designe: The select usually targeted to the coding 
sequences or 3’ UTR and contains
SNPs were avoided as well as c liced 
mRNAs. Importantly the 5´end of the antisense strand was thermodynamically 
destabilized in order to favor its inco
length from the co
ral common rules that the RNAi oligo retriever 
ed sequence was 
 >3 mismatches to any other gene. Furthermore 
ommon exons targeted in alternatively sp
rporation into RISC. 
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Sequences of 97mers:    
MH3 5´ TGCTGTTGACAGTGAGCGCGGGCCTCCTTGAGTGATACAATAGTGAAG 
CCACAGATGTATTGTATCACTCAAGGAGGCCCTTGCCTACTGCCTCGGA 3´ 
MH4 5´ TGCTGTTGACAGTGAGCGAGCAGCTACCTGGAACTCCTTATAGTGAAG 
CCACAGATGTATAAGGAGTTCCAGGTAGCTGCCTGCCTACTGCCTCGGA 3´ 
MH5 5´ TGCTGTTGACAGTGAGCGAGCCCAGCTACCTTGTACACTTTAGTGAAGC 
CACAGATGTAAAGTGTACAAGGTAGCTGGGCCTGCCTACTGCCTCGGA 3´ 
ACAGTGAGCGCGGCTGGCACAGTGCAATGAAATAGTGAAG 
CTGCCCGGA 3´ 
e LMP vector, unique 
TATTGCTGTTGACAGTGAGCG 3´; 
CCGAGGCAGTAGGCA 3´).  
am 
MH6 5´ TGCTGTTG
CCACAGATGTATTTCATTGCACTGTGCCAGCCATGACTA
 
 
Amplification of the unique CIITA short hairpin sequence 
In order to clone the CIITAsh into the miRNA30 backbone on th
restriction sites were inserted by PCR amplification: 
(XhoI-MH7 5´CAGAAGGCTCGAGAAGGTA
EcoRI-MH8  5´ CTAAAGTAGCCCCTTGAATT
 
 
PCR-mix PCR-progr
10µl               MgCl2 (25mM)   94°C             1min 
1µl                 Advantage II  
10µl            10x Buffer 
10µl  dNTP (2mM) 
5µl  XhoI primer (10µM) 
5µl  EcoRI primer (10µM) 
5µl   GCmelt (Clontech) 
44µl  dH2O 
10µl  97mer (0.1µM) 
94°C  30sec 
54°C  30sec 
75°C  1min 
75°C  10min 
15°C  hold 
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The PCR product (138bp) was loaded on an agarose gel and purified with the 
sertion, the DNA was digested with XhoI and SacII 
hich resulted in two products, 7019bp and 985bp if insertion was successful. 
etroviral vectors were ready for testing in vitro. 
 
Qiagen Gel Extraction Kit. The PCR product as well as the LMP vector was then 
digested with EcoRI and XhoI and again purified. After dephosphorylation of the LMP 
vector, the PCR product was ligated into the LMP vector (scheme). The Ligation was 
then transformed into DH5α bacteria that were subsequently streaked on plates with 
ampicillin and incubated at 37°C over night. Next day colonies were picked and 
incubated in 4ml LB plus ampicillin over night to perform minipreps next day. To 
identify clones with the proper in
w
R
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Retroviral infection of B cell line 
ht at 
. 
000 
 GFP 
xpression and subsequently infection of B cells could be performed. Supernatant 
as cleared from cells with a 0.45µm syringe filter and polybrene was added (4µg/ml 
supernatant containing 
Puromycin selection was started 
48h after the last infection to obtain stable clones. 
eneration of the transgenic CIITAkd mouse 
loning RE targeting construct 
The tar e B C generated by PCR-
amplific sh flank 5´ and 3´ flanking 
regions u peI sites (prove reading polymerase was used). 
 
EcoRV- 2 ´ AT T GGCGCCG 3´    
SpeI-M  5 CCG CCC  3´  
 
The PCR product (328bp) was gel purified and subsequently digested with EcoRV 
and SpeI to be ligated into the hogness #56 instead of HA (see scheme below). 
 
Transient transfection of virus producer cells (Phoenix): 
Phoenix cells were seeded (1.5x106 cells per 6cm plate) and incubated over nig
37°C and 5% CO2. Next day cells were adherent and formed a 70% confluent layer
Phoenix cells were transfected with 1-10µg vector DNA using Lipofectamin2
(Invitrogen) according to the manufacturers protocol. DMEM medium without FCS 
and antibiotics was used. Transfection was repeated 24h later.  
One day after the last transfection efficiency was controlled by measuring
e
w
final). 0.5x106 B cells (WEHI279.1) were resuspended in the 
the virus and incubated at 37°C and 5%CO2. Infection procedure was repeated next 
day and infection efficiency was checked 48h after. 
 
G
C  of the AI
geting construct used for th A  modification was 
ation of the miRNA30-CIITA ed by the miRNA30 
 introd cing EcoRV and S
MH2 : 5 GGGATATCCACTCC TCTCTA
H23: ´ A GACTAGTGGAAAAGCGCCTC TACC
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The targeting construct was recombined into the mouse BAC RP23-77011 which 
contains 58kb downstream and 152kb upstream from the transcription start site of 
AIRE (BACPAC Resources Center, Oakland, USA (246). Homology boxes spanning 
nucleotides -379 to -2 (5’: box1) and 17 to 399 (3’: box2) (with A of the start-codon 
being +1) were used for homologous recombination of the miR30-CIITAsh into the 
AIRE locus.  
 
BAC modification 
Transformation of BAC with pBAD 
DH10β bacteria containing the BAC RP23-77011 were grown in 4ml LB 
supplemented with chloramphenicol (12.5µg/ml) over night at 37°C. Bacteria were 
then spun down at 10000 rpm for 2min and resuspended in 1ml ice-cold 10% 
lycerol. This washing step was repeated twice followed by electroporation (200Ω, 
5uFD, 2,5kV) of bacteria in 50µl 10% glycerol with 500ng pBAD. pBAD encodes for 
e recombinase required for BAC modification later on. LB was added to the 
g
2
th
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transformed bacteria and incubated for 1h at 37°C without antibiotics. After that 
th chloramphenicol and 
ampicillin (100µg/ml) and incubated on 37°C over night. 
own in 70ml LB plus 
ampicillin and chloramphenicol at 37°C until OD600=0.1. At that point L-arabinose was 
d on LB plated supplemented with 
anamycin and chloramphenicol at 37°C over night.  
 
bated over night with LB plus kanamycin 
creening scheme 
KA9 and KA10 identified empty vectors, MH40 and MH23 amplified positive clones 
nd KA8 and KA10 were used to check for the loss of neomycin. TD5430 PCR 
program was used in all cases. 
Left over of the LB culture of the positive clones was diluted 1 to 1000 and one drop 
was plated on kanamycinan/chloramphenicol LB plates and incubated at 37°C over 
periode, bacteria were plated on LB plates supplemented wi
 
Transformation and recombination of insert 
3 colonies were picked next day and again incubated in 2-4ml LB plus ampicillin and 
chloramphenicol over night. Next day 1ml of the culture was gr
added and bacteria were further grown until an OD600 of 0.3-0.4 was reached.  
Bacteria were spun down at 7000rpm for 5min and washed 3 times with 1ml cold 
10% glycerol. The supernatant was then discarded and bacteria were resuspended 
in remaining glycerol. 400-1000ng insert (targeting construct digested with AhdI and 
SalI) was added and bacteria were electroporated (see pBAD transformation). 
Transformed bacteria were incubated at 37°C for 1.5h. In order to select for 
recombination of the insert, bacteria were streake
k
Screening for positive clones 
Next day 12 colonies were picked and incu
and chloramphenicol. From these cultures DNA was isolated using Quiagen Miniprep 
kit and tested for successful recombination via PCR.   
 
S
 
 
         400bp            600bp           330bp        140bp      1170bp         400bp    
 
   KA9                   MH40          MH23   KA8          KA10 
 
a
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night.  On the next day, 50 colonies per plate were picked and replica-plated first on 
plates with ampicillin and second on plates with chloramphenicol/kanamycin plates. 
Those clones that were growing on chloramphenicol/kanamycin plates but not under 
ampicillin selection already lost the recombinase plasmid and can therefore be 
further used. 
 
Deletion of kanamycin resistance 
In order to delete the kanamycin resistance, bacteria were transformed with the flp-
plasmid carrying the flp recombinase. For that purpose 4 clones were inoculated in 
2ml LB supplemented with kanamycin and chloramphenicol over night. Next day 
cultures were washed and transformed with approximately 300ng of flp-plasmid. 
Transformed bacteria were first incubated at 30°C for one hour and subsequently 
streaked on LB plates supplemented with tetracyclin and incubated on 30°C over 
night. 
Next 6 clones from different tetracyclin plates were inoculated in 2ml LB without 
antibiotics over night on 37°C leading to the loss of the flp plasmid. To test for the
eletion of the kanamycin resistance over night cultures were diluted 1 to 1000 and 
yclin second chloramphenicol and third chloramphenicol/kanamycin 
lates. In parallel the very same clones were inoculated in 4ml LB with 
r night at 37°C.  
only growing on chloramphenicol plates were 
 
d
streaked on chloramphenicol plates and on plates containing both chloramphenicol 
and kanamycin plates were incubated at 37°C over night. Those clones that grow 
significantly less on kanamycin/chloramphenicol plates were tested for the loss of the 
kanamycin by PCR (see screening scheme). Those clones that were screened 
positive for the loss of the kanamycin resistance were again tested and replica plated 
on first tetrac
p
chloramphenicol ove
The 4ml LB culture of clones that were 
used for injection. 
    
Large scale preparation of BAC DNA 
One or two clones that positively passed all screening procedures were inoculated in 
2 x 1l LB with chloramphenicol at 37°C over night.  Cultures were centrifuged and 
pellet were resuspended in buffer P1 (45ml P1 per 1l culture, Maxi Prep Quiagen). 
To lyse the cells 15ml of P2 was added per 45ml bacteria suspension and the lysate 
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was incubated for 15min at room temperature. Next 15ml buffer P3 was added 
followed by a 20min incubation step on ice and a centrifugation step for 30min at 
4500rpm. After that the supernatant (filtered) was loaded on equilibrated columns (6 
er 2l culture) and columns were washed 2x with 30ml wash buffer. BAC DNA was 
h 10.5ml 
le was mixed, spun down and 
upernatant was discarded. This step was repeated several times. 
ffer for several days whereas the buffer 
830ml H2O 
7.5) 
ml EDTA (0.5M) 
NaCl (100mM final) 
t n fo pronuclear jecti
centration of 1ng/ml. 
p
eluted with 15ml pre-warmed elution buffer per column and precipitated wit
isopropanol. After 1h centrifugation a small pellet was visible which was then 
transferred to an eppendorf tube and washed 3x with 70% Ethanol. Finally the DNA 
was air-dried and resuspended in 500µl TE-buffer.  
 
BAC DNA purification – Cesiumchloride gradient 
Two snap cap tubes with 4.4g of cesiumchloride were filled with either 4400µl TE-
buffer or 4150µl BAC DNA and 250µl EtBr. As soon as the cesiumchloride was 
dissolved, solutions were transferred to Vt.65.2 Beckman centrifuge tubes, balanced 
and sealed. The gradient was ultra centrifuged at 58000rpm at 22°C for 17h (Vt.65.2 
rotor). Next day the purified BAC DNA was recovered under the UV light. To extract 
the DNA, 1ml isoamylalcohole was added, the samp
s
The DNA was dialyzed against injection bu
was changed every day. 
 
10x injection buffer 
1
160ml TRIS (1M, pH 
4
 
BAC DNA prepara io r  in ons 
After dialysis BAC DNA concentration was determined by spectrophotometry. The 
quality was controlled on a 0.5% agarosegel. For pronuclear injections DNA was 
diluted in injection buffer to a con
 
 
 
76 
 
Bone marrow chimeras  
Bone marrow was obtained from donor mice by isolating tibia and femur and flushing 
out the bone marrow mass using a syringe and a needle. Single cell suspension was 
made and subsequently bone marrow was depleted from T cells using biotinylated 
CD8 and CD4 mAbs and streptavidin MACS beads (Myltenyi) according to standard 
rocedures. Balb/c and BL6 recipient mice were lethally irradiated with 2x450rad and 
ted by injecting 6-8x106 bone marrow cells into 
 HA107-119 peptide (SVSSFERFEIFPK, recognized by the TCR-HA in the 
d
92mg/ml L-Glutamin  
p
2x550rad respectively and reconstitu
the tail vein. Chimeras were analyzed 5-6 weeks after reconstitution. 
 
Antigen-presentation assay 
2 x 104 A5 T cell hybridoma cells were co-cultured with 1 – 2 x 104 antigen presenting 
cells (APC) in 200 µl IMDM supplemented with 1% FCS in 96-well round bottom 
plates.
context of I-E ). GFP expression of A5 T cells was measured by flow-cytometry 19h 
later.  
 
In vitro assay 
5 x 104 CD4+SP thymocytes were co-cultered with 2.5x104 thymic APCs in IMDM 
supplemented 10% FCS, PenStrep glu?,b merc. H3 thymidine was added to the 
culture on day 3 (1µCu/well) and thymidin incorporation was measured 19h later 
using a scintillation counter.  
 
Media for primary T cell culture  
IMDM (Gibco)  
10% FCS  
0.2
100U/ml Streptomycin  
100U/ml Penicilin  
50μM β-Mercaptoethanol 
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Isolation of thymic epithelium 
Thymi were disenthralled from connective tissue and fat, cut into very small pieces 
using scissors and transferred to pre-warmed digestion medium (IMDM containing 
0.2 mg/ml Collagenase (Roche), 0.2 mg/ml DispaseI (Roche), 2% FCS, 25mM 
HEPES (pH 7.2) and 25 μg/ml DNase I). 1ml digestion medium was used per 
thymus. Digestion was performed in a FACS tube at 37 °C; First the suspension was 
mixed using a 1000µl pipette, later on the 200µl pipette was used to digest the 
epithelial cells and DC out of the matrix. After about 45-50min the cell suspension 
as transferred to 4°C followed by the addition of EDTA (5 mM final) for 5min at RT. 
ended in PercollTM (ρ 1.115; 
w
Cells were filtered and washed in PBS and resusp
GEHealthcare). A second layer of Percoll (ρ 1.055) and a third layer of FACS buffer 
was carefully added on top. 
The Percoll solutions were prepared as follows: 
 
ρ 1.115 ρ 1.055 
9x Percoll stock (ρ 1.134) 
1x PBS (10x) 
1x Percoll (ρ 1.115)  
1.09x PBS (1x) 
25mM HEPES pH=7.2 (final)     
 
The densities were calculated according to the following formula: 
Vy…volume of diluting solution (PBS) 
Vi…volume of Percoll stock solution 
)  /  (Dii-Dy)                Di…density of Percoll stock solution 
Di…desired density 
Dy…density of PBS (=1) 
Optionally the low density Percoll solution can be decreased or increased to ρ 1.050 
 acceleration and 
ning the desired low density cell fraction, 
as harvested and washed in FACS buffer. Cells were now ready for staining.  
 
 Vy=     Vi x (Di-Dii
 
or ρ 1.060 respectively. 
 
 After that the gradient was centrifuged at 4°C and 1350g without
break for 30min. The upper interface, contai
w
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RNA isolation 
Total RNA was isolated from FACS sorted thymic stromal subsets using the 
miRNAeasy kit (Qiagen) including an on column DNAseI (Qiagen) digest according 
to the manufacturers recommendations. 
 
Quantitative PCR 
 
RNA was reverse transcribed using the iScript cDNA synthesis kit (Biorad) according 
ndations.  
 
g conditions 
94°C for 180sec  
   40x (plate read) 
Primers: 
quence 
to the manufacturers recomme
qPCR reactions were performed in duplicates on a CFX96 realtime thermal cycler 
(Biorad) using the myIQ sybrgreen mastermix (Biorad) in 10µl reactions according to 
the manufacturers recommendations. Primers were used at 500nM each.  
Cyclin
94°C for 10sec 
56°C for 20sec 
72°C for 20sec 
Melting curve analysis 
 
gene product se
actb   97bp 5´  GCCTTCCTTCTTGGGTAT 3´ 
 5´ GGCATAGAGGTCTTTACGG 3´ 
Aire 117bp 5´ CCTTATCCAGCAGGTGTTT 3´ 
5´ CGGGCCTTGTTCTTCA 3´ 
HA 147bp 5´ GCTGGGAGGATGAACTATTA 3´ 
5´ CATTGATGCGTTTGAGGT 3´ 
H2-IA-alpha 185bp 5´ GGCTCAGAAATAGCAAGTCA 3´ 
5´ AATCTCAGGTTCCCAGTGTT 3´ 
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C2TA 148bp 5´ CCTATGCCAACATTGCG 3´ 
5´ GGCTTCTGTCCTGCTTCTA 3´ 
H2-K (pan MHCI) 
  
151bp 5´ GATTACATCGCCCTGAACG 3´ 
5´ GGTATCTGCGGAGCCACT 3´ 
  
Relative expression levels were calculated using the comparative Ct method using 
actb for normalization. 
 
Small RNA quantification 
A custom small RNA assay for the detection of UUUCAUUGCACUGUGCCAGCCA 
d by Applied Biosystems. 
otal RNA including the smallRNA fraction was isolated from FACS sorted thymic 
ubsets (see above) using Aeasy kit (QIAGEN) including an on 
 digest acc urers recommendations. 
tely 21  cells ere verse transcribed using specific 
RNA (snoRNA202) and the mature C2TA 
 
it (Applied Biosystems) according to the manufacturers recommendations. 
cDNA reactions were diluted 5 fold and ctions 
were run in duplicate using primer / probe combinations for snoRNA202 and C2TAsh 
pErase 
UNG (Applied Biosystems) in 20ul to the manufacturer´s 
recommendations. Fluorescence was  step and relative 
xpression levels were calculated with the comparative Ct method using snoRNA202 
 
(mature C2TAsh) was designed and manufacture
T
stromal s the miRN
column DNAseI (QIAGEN) ording to the manufact
RNA equivalents of approxima 00  w re
RT primers for mouse small nucleolar 
antisense shRNA (C2TAsh) (Applied Biosystems) using the TaqMan microRNA RT
k
 used as template for PCR.  PCR rea
(Applied Biosystems) and the TaqMan 2x Universal PCR Master Mix, No Am
reactions according 
recorded at the annealing
e
for normalization. 
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Genotyping 
 
ffer at 55°C for 5h. Proteinase K inactivation 
was carried out at 95°C for 5min.  
 buffer (10x)  
70mM Tris pH 8.8  
.1% Gelatin  
2.5μl Triton (10% Stock)  
0x)  
ethanol  
 for genotyping. 
250mM KCl  
0mM Tris pH 8.3  
rol  
7.5mM MgCl2  
resol Red  
il digest 
2.5mM primers (final)  
M dNTP (final)  
PCR Buffer (1x final)  
se  
Ad 30μl with H2O  
DNA preparation 
 
Tails were incubated in 50µl digestion bu
 
Gitocher digestion
6
166mM ammonium sulfate  
65mM MgCl2  
0
 
Digestion buffer  
3μl Proteinase K (10mg/ml stock)  
5μl Gitocher Buffer (1
0.5μl β-Mercapto-
39μl H2O  
Subsequently 1µl of the DNA was used
 
PCR Red-buffer (5x) 
5
43% Glyce
2mM C
 
PCR reaction 
1μl ta
200μ
Taq Polymera
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All genotyping reactio  ca am. 
 
 
 cycles 
 
 
 
ns were rried out using the TD54x30 progr
TD54x30 
 
 3min at 94°N 
45sec at 94°C 
45sec at 60°C     2
60sec at 72°C 
45sec at 94°C  
45sec at 58°C    2 cycles 
60sec at 72°C 
45sec at 94°C 
45sec at 56°C    2 cycles 
60sec at 72°C 
 
45sec at 94°c 
45sec at 54°C    30 cycles 
60sec at 72°C 
10min at 72°C 
 
 
Primers used for genotyping 
 
gene primer sequence 
CIITAkd  MH40 fwd 5´  TAAATTCTGGCTGGCGTGG 3´ 
CIITAkd  MH23 rev 5´ ACCGGACTAGTGGAAAAGCGCCTCCCCTACC 3´ 
TCR-HA  6.5 5´ fwd 5´ ACAAGGTGGCAGTAACAGGA 3´ 
TCR-HA  6.5 3´ rev 5´  ACAGTCAGTCTGGTTCCTGA 3´ 
AIRE-HA  KA9 fwd 5´ ACAGCCACTCCTGTCTTTGC 3´ 
AIRE-HA  HA3 rev 5´ CTCCGTCAGCCATAGCAAATTTCT 3´ 
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pgk-HA  HA 5 fwd 5´ GGCTACCATGCGAACAATTCAACCG 3´ 
pgk-HA  HA 3 rev 5´ CTCCGTCAGCCATAGCAAATTTCTG 3´ 
AIRE-HCO  KA9 fwd 5´ ACAGCCACTCCTGTCTTTGC 3´ 
AIRE-HCO  JE12 rev 5´ GAATTGTTCGCATGGTAGCC 3´ 
DO11.10  DO11.10 5´ fwd 5´ CAGGAGGGATCCAGTGCCAGC 3´ 
DO11.10  DO11.10 3´ rev 5´ TGGCTCTACAGTGAGTTTGGT 3´ 
CD11c-Cre  Cre 5´ fwd 5´ CGATGCAACGAGTGATGAGG 3´ 
CD11c-Cre  Cre 3´ rev 5´ GCATTGCTGTCACTTGGTCGT 3´ 
DTA  DTA 5´ fwd 5´ TACATCGCATCTTGGCCACG 3´ 
DTA  DTA 3´ rev 5´ CCGACAATAAATACGACGCTG 3´ 
AIRE-Gfp  GFP1 fwd 5´ AAGTTCATCTGCACCACCG 3´ 
AIRE-Gfp  GFP2 rev 5´ TCCTTGAAGAAGATGGTGCG 3´ 
Rag2  Rag 5´ fwd 5´ GCAACATGTTATCCAGTAGCCGGT 3´ 
Rag2 rev Rag 3´ 5´ TTGGGAGGACACTCACTTGCCAGT 3´ 
Rag2 int Rag int 5´ GTATGCAGCCGCCGCATTGCATCA 3´ 
CIITA wt  CIITA1869 fwd 5´ GATCGGAGACAAGGGTGTGT 3´ 
CIITA wt  CIITA1870 rev 5´ GTCAGGGAGCAGGATCTTTG 3´ 
CIITA ko  CIITA 158 fwd 5´ CTGAATGAACTGCAGGACGA 3´ 
CIITA ko  CIITA 159 rev 5´ ATACTTTCTCGGCAGGAGCA 3´ 
MHCII  MA295 fwd 5´ TTCGTGTACCAGTTCATGGG 3´ 
MHCII MA296 int 5´ TAGTTGTGTCTGCACACCGT 3´  
MHCII  MA297 rev 5´ CCTGCCGAGAAAGTATCCA 3´ 
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